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ABSTRACT
The goal of my dissertation research is to develop implantable sensors that attaches
to prosthesis prior to implantation and measures biomarkers of infection in joint fluid in
order to detect, monitor and study infection using plain radiography. Joint replacement
surgeries are common procedures improving the mobility and lives of millions of people
worldwide. Although the surgeries are generally successful, about 1% of prosthetic hips
become infected. If the infections are not detected and treated promptly with antibiotics
and surgical debridement, device removal is almost always required to treat the infections.
Therefore, it’s important to detect post-surgery infections early and monitor the effect of
therapies for effective treatment. The sensors developed in this report can be attached to
prosthetic joints and enable analysis of synovial fluid biomarkers for local infection in vivo
using plain radiography. The biomarkers of infection focused here are pH, carbon dioxide
and viscosity of synovial fluid. The pH and carbon dioxide sensors are based on a pH
responsive hydrogel, whereas the viscosity sensor is based on the velocity of a falling bead.
Radiopaque markers are incorporated into the sensor to enable biochemical measurements,
radiographically. The sensors can be expanded to other biomarkers of infections, as well
as other disease conditions. The sensors developed provide noninvasive local chemical
measurements using plain radiography which are simple, rapid, and already acquired as
part of the standard of care for early detection of prosthetic joint infections.
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CHAPTER ONE
INTRODUCTION
We designed implantable sensors that can be attached to hip prosthesis to detect
and monitor biomarkers of infections for prosthetic joint infections using standard of care
X-ray imaging. Hip replacement surgeries are performed on millions of people worldwide
each year. In the United States alone, there were 450,000 total hip arthroplasties performed
annually. Most of these surgeries are successful with no complications. However,
infections are a leading cause of failure, with an incidence of about ~0.5-2% of total hip
replacement surgeries. If detected early, these infections can be treated promptly with
antibiotics and surgical debridement. However, mature biofilms usually require implant
removal to treat the infection, followed by revision surgery with associated risks of
morbidity, mortality, and large cost. Therefore, it’s important to detect post-surgery
infections early and monitor the effect of therapies for effective treatment.
X-ray imaging is ubiquitously available in hospitals, easy to use, and is part of the
standard of care for many medical conditions, to show anatomical changes, especially
orthopedics. Radiographs are also routinely used in preclinical research as well. However,
they are usually blind to chemical concentrations, which are measured only after invasive
aspiration or biopsy procedures. Alternatively, molecular imaging approaches can detect
some relevant disease features, but are expensive, not available everywhere, slow
compared to plain radiography. We developed implantable X-ray visualized sensors to
measure local biomarkers of synovial fluid infections. The X-ray based implantable sensors
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used in our studies are based on the pH responsive swelling mechanism of polyacrylic-acid
hydrogels, where the hydrogel swelling moves an embedded tantalum bead relative to a
scale for simple readout on X-ray. The sensors are small enough to be incorporated into
various biomedical implants on the market. Unlike other implantable sensors, these devices
do not use any electronics, battery, or telemetry which greatly improves reliability and
makes it much easier to develop, manufacture, and integrate into clinical applications. This
technology has the potential to transform biomedical research and clinical practice.
I worked in close collaboration with my colleague, Sachindra Kiridena, on
developing unique X-ray based sensors for different applications including synovial fluid
pH sensor for early detection of hip infections (co-first author in journal article published
in Advanced Functional Materials), peritoneal fluid pH sensor for early detection of
peritonitis, injectable tumor pH sensor to determine tumor acidosis, and miniaturized the
sensor for imaging tumor pH heterogeneity using an array of hydrogel pillars using
ultrasound and micro-computed tomography. We also worked on developing sensors based
on other biomarkers for different biomedical applications related to infection and cancer
including sensors for measuring carbon dioxide, C-reactive protein, glucose, viscosity,
moisture, matrix metalloproteinases.
This dissertation focuses on three of the sensors for applications for early detection
of prosthetic joint infections by local measurement of synovial fluid biomarkers of
infection; hydrogel-based pH sensor; hydrogel-based carbon dioxide sensor; an X-ray
interrogated falling bead synovial fluid viscosity sensor. These sensors can be easily
attached to the prosthesis and provides useful biochemical information at the site of
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infection itself. The sensor design is simple enough to be extended for any implant and can
be extended for a broad range of biomarkers for different disease conditions.
The following sections in this chapter cover some background on orthopedic
implant infections, it’s current challenges in diagnosis and treatment, and the importance
in developing X-ray visualized chemical sensors to overcome these challenges, with
potential to transform orthopedic applications for detecting, monitoring, and studying
implant infection.
1.1. Joint replacement surgeries
Joint replacement surgeries are life-enhancing procedures with the purpose of
restoring joint function, relief from pain, and overall improvement in quality of life of
patients with joint dysfunctions.1,2 Patients undergoing joint surgery include people
suffering from accidents and joint diseases like osteoarthritis, rheumatoid arthritis.3,4 In the
US alone, more than 450,000 total hip arthroplasties are performed annually.4 During joint
replacement surgeries, the patient’s joint is replaced with a prosthetic implant made of a
biocompatible material such as metallic alloys, ceramics, and polymers. 3 Currently, it is
possible to perform total joint replacement surgeries in most of the major joints in humans,
such as hip, knee, shoulder, elbow, wrist, ankle, spine, etc. using a wide range of orthopedic
implants.
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1.2. Prosthetic joint infections
One of the leading causes of failure following joint replacement surgery are postsurgery infections with an incidence of about ~0.2-3% of primary total hip or knee
replacement surgeries.4,5 Prosthetic joint infection refers to an infection involving the
prosthesis and tissues surrounding the implant through direct contamination during
surgery, hematogenous spread as a result of bacteremia related to a remote site of infection,
or as a contiguous infection due to contact with an adjacent site of infection or open
wound.6,7 Complications of post-surgery infections involve prolonged hospitalization,
multiple operations, significant permanent deformity, or loss of the implant. In the elderly
it may result in a higher incidence of mortality as well.5,8 Risk factors for infection include
obesity, diabetes mellitus, rheumatoid arthritis, exogenous immunosuppressive
medications, and malignancy.6,9 Occurrence of prosthetic joint infections is a most
challenging complication and pose significant risks for patient mobility, other morbidities
and mortality (5% 2-month mortality following prosthetic joint infection in 2015),10 as well
as staggering hospital costs (cost of treatment $100,000 per episode,11 and lifetime
treatment cost for a 65-year-old is an estimated $390,806).12 The projected total direct cost
in the US in 2030 for prosthetic joint infections is $1.8 B ($753 M for hip).13
Infection associated with prosthetic joints are caused by microbial contamination
of the prosthesis.9,14,15 The most common cases of joint infections are caused by
staphylococci

species

such

as

Staphylococci

aureus and

coagulase-negative

staphylococcus species.16 The prosthetic implant/ joint provides a surface for the
attachment of microbial cells. On initial contact with blood, plasma proteins are adsorbed
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onto the surface of the prosthesis forming a “conditioning film” for which microorganisms
can adhere.2,17,18 The microbes grow to form a monolayer, which later develops into a
microcolony and eventually a biofilm is formed where the microbes are enclosed in a
polymer matrix.19 The biofilm protects the microbes from conventional antimicrobial
agents and the host immune system, thus resulting in increased resistance to antibiotics and
host immune responses.20,21
Prosthetic joint infections can be classified as early (1-4 weeks), delayed (3 to 24
months after surgery) or late (more than 24 months after surgery), based on the time of
infection.22 Early infections are commonly caused by virulent microorganisms, such as S.
aureus and gram-negative bacilli, resulting in acute onset of joint pain, effusion, erythema
and warmth at implant site, and fever.23 Delayed infections are caused by less virulent
microorganisms, such as coagulase-negative staphylococci and Propionibacterium acnes.
Patients usually show subtle signs and symptoms, such as implant loosening, persistent
joint pain. Early and delayed infections are usually acquired during implantation of the
prosthesis. Late infections are caused by low virulence organisms such as P. acnes and
occur mainly due to hematogenous seeding (from infections in skin, respiratory tract,
dental, and urinary tract). If detected early, these infections can be treated promptly with
antibiotics and surgical debridement. However, mature biofilms usually require implant
removal followed by reinsertion of the medical device after the infection is eradicated.
Therefore, it’s important to detect post-surgery infections as early as possible for effective
treatment.24,14
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1.3. Current diagnosis of prosthetic joint infections
The diagnosis of post-surgery infections is based upon a combination of clinical
findings based on nonspecific symptoms, laboratory results from peripheral blood and
synovial fluid, microbiological data, histological evaluation of periprosthetic tissue,
intraoperative inspection, and imaging techniques such as X-ray, magnetic resonance
imaging (MRI), computed tomography (CT).25,26 Nonspecific post-surgery infection
symptoms include pain, joint swelling (effusion), warmth around the joint (erythema),
fever, drainage, or the presence of a sinus tract (narrow opening or passageway underneath
the skin that can extend in any direction through soft tissue and results in dead space with
potential for abscess formation) communicating with the arthroplasty.27 Laboratory tests
include systemic measures of inflammation: erythrocyte sedimentation rate (ESR) greater
than 30 mm/h, serum C-Reactive protein (CRP) levels greater than 10 mg/L; local measure
of synovial inflammation: synovial white blood cell (WBC) count greater than 3000
cells/µL, or a synovial neutrophil differential percentage greater than 65%, synovial tissue
histology greater than 5 neutrophils per high-power field on frozen section; bacterial
isolation techniques including Gram stain and bacterial culture with a pathogen isolated by
culture from two separate tissue or fluid samples obtained from the affected prosthetic joint
or/and isolation of a microorganism in one periprosthetic tissue or fluid culture;
radiographic tests including radiographs, bone scan, MRI, CT, positron emission
tomography.22,28 In order to address inconsistencies in diagnosing joint infections with
these tests, the Musculoskeletal Infection Society (MSIS) published a concise definition of
a prosthetic infection. It requires either one of two major criteria (sinus tract
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communication with a prosthesis or a pathogen isolated by culture from two separate fluid
samples), or four of six minor criteria (elevated ESR, elevated CRP, elevated WBC count,
elevated synovial neutrophil differential percentage, presence of purulence, and greater
than 5 neutrophils per high-power field on frozen section).29 Although clinically useful,
this definition remains complex and time consuming. In addition, there are several
drawbacks of the current diagnostic methods. For example, radiographic images may
indicate infection via bone erosion, implant loosening, and/or sinus tracts,30 however, the
technique lacks sensitivity and specificity for infection and cannot be used to detect early
stages since bacteria are often localized to inaccessible regions on implant surfaces. MRI
and CT imaging techniques are able to detect bone resorption and sinus tracts, which relate
to local acidosis, but are unhelpful until later stages of infections.31,8 Research using
intraoperative pH electrode measurements have indicated that infected devices develop
local acidosis from bacteria and neutrophils during infection.32 Histological tissue
examination provides high sensitivity and specificity, however neutrophil infiltration
varies significantly even within the specimen and there is no accepted definition for acute
infection.26, 33 Bacterial culturing from tissue or intraoperative samples typically need at
least three “positive” cultures before the area can be considered infected. 33 Therefore, it’s
imperative to develop more sensitive/specific methods to detect and monitor prosthetic
joint infections.
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1.4. Synovial fluid analysis for prosthetic joint infections
Synovial fluid is the viscous solution found in the cavities of synovial joints which
are joints that allow a large range of motion and encompass wrists, knees, ankles,
shoulders, and hips.34 Synovial fluid is a highly viscous, straw colored, clear fluid which
provides lubrication and nutrition to the joint. The amount of synovial fluid in normal joints
varies from a few drops in small joints to several milliliters in larger joints (e.g. a normal
knee joint may contain up to 3–4 mL of synovial fluid).35
Synovial fluid is a combination of a dialysate of blood plasma filtered through the
synovial membrane and components secreted by the joint tissues. The main component of
synovial fluid is hyaluronic acid (2 and 4 mg/mL in normal synovial fluid)36,37 which is
secreted by the synovial cells and polymerizes with proteins in synovial fluid to form a
hyaluronic acid-protein complex that functions as a viscous lubricant within the joint.3438
The concentrations of small molecules like electrolytes will be similar to those in plasma
since it’s an ultrafiltrate of plasma. However, larger molecules like proteins are present in
low concentrations (25% that of plasma), unless an inflammatory condition alters
vasopermeability.39,40
Changes in volume and composition of synovial fluid reflect changes within the
joint, especially during infection. Some physical changes include change in clarity from
clear to opaque (due to increased number of leukocytes), change in color (formation of pus
may give an off-white color to synovial fluid), viscosity (decreases due to depolymerization
of the hyaluronic acid by polymorphonuclear leukocyte enzymes). Changes in chemical
composition may include elevated lactate, lactate dehydrogenase, proteins, decreased pH
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and glucose levels. Therefore, synovial fluid is potentially of great diagnostic significance
for joint infection diagnosis.
As discussed previously, the current standard of care detection involves systemic
markers of inflammation (ESR, CRP) which do not localize the inflammation source and
have poor sensitivity/specificity for implant-associated infection. In recent years,
researches on post-surgery infection diagnosis have started to focus on synovial fluid
instead of serum since synovial fluid is the site of primary infection and it is believed that
the diagnosis should be more sensitive than that of serum, theoretically.41 Arthrocentesis
or joint aspiration is a common procedure carried out if infection is suspected. During the
procedure, the joint is aspirated using a syringe to collect synovial fluid from a joint
capsule. In general clinical practices, the aspirated synovial fluid is then analyzed for
synovial fluid WBC count and differential, synovial tissue histology as mentioned
previously. Synovial fluid analysis adds further confidence to the diagnostic of infection,
avoiding unnecessary surgeries, however, none of these can be considered reliably
predictive on its own.42 Recently, large number of studies have been carried out to
determine a suitable biomarker specific for prosthetic joint infections which can be used
for infection diagnosis such as glucose, low pH/high lactate concentrations,43–45 leukocyte
counts,46,47 other biomarkers of infection such as leukocyte esterase,46,48,49 CRP,41,46,50
interleukins,50–52 interferon‐γ,25,50 α defensin.53–55 However, analysis of these biomarkers
also require collection of synovial fluid by arthrocentesis which is not practical for routine
screening or serial monitoring during treatment, since the procedure is expensive, painful
and needs to be performed by a radiologist under image guidance (such as fluoroscopy,

9

ultrasound, MRI or CT),8,22 with reported complications including allergic reactions to the
local anesthetic or the contrast agent used.56 In addition, improper/inadequate fluid
aspiration or delayed measurement can confound analysis and substantial dilution of
synovial fluid with saline or blood during collection (caused by the presence of a
hemarthrosis or a dry tap), result in poor quality synovial fluid specimens with diluted
biomarkers, decreasing the sensitivity of the laboratory testing.57,58 Therefore, there is need
for the development of efficient diagnostic methods to measure local synovial fluid
biomarkers to determine post-surgery infections as early as possible for effective treatment.

1.5. X-ray visualized chemical sensors for synovial fluid analysis
Physicians routinely use X-ray imaging to image anatomy and associated
pathologies because they penetrate through deep tissue and show contrast between air, soft
tissue, bone, and metal hardware.59 An X-ray based sensor inserted during surgery would
be painless, rapid, non-invasive, inexpensive, enable serial measurements at the same
location (or locations for comparative local analysis) and fit with current standard of care.
However, X-rays are usually blind to local biochemical information and insensitive to
small biomechanical changes which are critical for studying, detecting, and monitoring
pathologies associated with implant-associated infection.59,60 At late stages of orthopedicimplant-associated infection, bone erosion near the implant is visible radiographically,30
however, these features are rarely present at early stages and difficult to quantify
objectively for infection monitoring. Our approach is to develop simple, passive sensors
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that can be easily incorporated into implants on the market and read using plain
radiography. These sensors would enable noninvasive local chemical measurements using
plain radiography, which is simple, rapid, and already acquired as part of the standard of
care.
Two of the sensors discussed in the dissertation are based on a stimuli responsive
hydrogel which is a water-swollen biomaterial which can expand or contract in response
to various physical and chemical stimuli.62,63 Hydrogels are cross-linked hydrophilic
polymers that contain large amounts of water.62,64,65 By incorporating functional groups, a
hydrogel can be made stimulus sensitive which can undergo volume changes in response
to changes in stimuli (pH, temperature, light, ion concentration or electric field, etc.). 62,63
Biomedical applications of stimulus-sensitive hydrogels include controlled drug delivery,
sensors, and actuators due to their good biocompatibility.66–69 Hydrogel-based sensors
usually consist of a particular stimulus-sensitive hydrogel, which is used as a sensing
element, and a transducer to convert the swelling of the hydrogel.70,71 In the presented
research, a pH responsive hydrogel based on polyacrylic acid72,73 was used for the studies
and radiopaque markers were incorporated in the hydrogel in order to determine length
changes radiographically.
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1.6. Description of dissertation
Chapter 1 introduces the hypotheses for the research presented in this dissertation
and explains the significance of research followed by a brief description of the research
explained in each chapter.
Chapter 2 describes the development of an X-ray based synovial fluid pH sensor
for the early detection of hip infections. The sensor was characterized in vitro, and the
sensor attached to a prosthetic implant was imaged through X-ray imaging.
Chapter 3 describes modification of the pH sensor as a carbon dioxide sensor by
separating the pH responsive hydrogel from the external environment by a gas permeable
membrane. The sensor was characterized in vitro, and the prototype sensor was imaged
through X-ray imaging. The sensor can be used to measure synovial fluid carbon dioxide
levels for the early detection of hip infections.
Chapter 4 describes an X-ray based synovial fluid falling bead synovial fluid
viscosity sensor for the detection of prosthetic joint infections. The sensor is based on
measuring the movement of a radiopaque bead through a series of X-ray images.
Chapter 5 provides an overall summary of the research with the implications of the
research. The chapter is concluded with potential directions for future studies including
development of implantable sensors responsive to other biomarkers of infection for the
early detection of joint infections.
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CHAPTER TWO
X-RAY BASED SYNOVIAL FLUID pH SENSOR FOR EARLY DETECTION OF
PROSTHETIC HIP INFECTIONS
2.1. Abstract
Hip replacement surgeries are generally safe and effective, however, about 1% of
prosthetic hips become infected. If infections are not detected and treated promptly, the
implant must be removed followed by reinsertion of the medical device after the infection
is eradicated. During infection, studies show that in a well-mixed synovial joint fluid, pH
correlates with white blood cell count and pH decreases from 7.5 to around 6.7 with a
threshold around 7. The sensor developed can be used to measure synovial fluid pH in
order to detect and monitor hip infections using plain radiography which is already
routinely acquired during patient follow up visits. The sensor was made of a pH responsive
polyacrylic acid-based hydrogel, which expands at high pH and contracts at low pH. A
radiodense tantalum bead and a metal wire were embedded in the two ends of the hydrogel
in order to monitor the change in length of the hydrogel sensor in response to pH via plain
radiography. The sensor showed a linear response and reversibility in the physiologically
relevant pH range of pH 6.5 and 7.5 in both buffer and bovine synovial fluid solutions. The
sensor was attached to a hip prosthetic implant and the change in length in response to pH
was determined from the X-ray images by measuring the length between the tantalum bead
and the radiopaque wire. Therefore, the developed sensor would enable noninvasive
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detection and studying of implant hip infection using plain radiography. Much of this
chapter is based on work published in Advanced Functional Materials, 2021.1

2.2. Introduction
Hip replacement surgeries are performed on millions of people worldwide each
year. During these surgeries, the hip is surgically removed and replaced with a prosthetic
component (Figure 1a).1 Successful joint replacement surgeries provide a safe and
effective procedure that relieves pain, restores function and independence, thereby
improving the quality of life of the patient.2,3 Most of these joint arthroplasties are
complication-free; however, one of the leading causes of failure following joint
replacement surgery are post-surgery infections with an incidence of about ~0.5-2% of
total hip replacement surgeries.4,5 If detected early, these infections can potentially be
treated with antibiotics and surgical debridement.6 However, after 3 to 4 weeks, bacteria
can produce biofilms that resist antibiotic treatment, which necessitates removal of
prosthetic implants and then reimplantation.2,7,8 As a result, these infections have high
morbidity, mortality and financial costs. Revisions typically cost around $50,000 per
patient with an estimated total hospital cost of $250 million per year to the healthcare
system in USA.9 Therefore, early detection of infections is very important for patients and
the healthcare system in general.
Current diagnosis of post-surgery infections is based on a combination of clinical
findings based on nonspecific symptoms, laboratory results from peripheral blood,
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microbiological data, histological evaluation of periprosthetic tissue, intraoperative
inspection, and imaging techniques (such as X-ray, MRI, CT).6,10 These procedures include
systemic markers of inflammation which do not localize the inflammation source and have
poor sensitivity/specificity for implant-associated infection. Infection markers can be more
sensitive and specific in synovial fluid (fluid around synovial joint) than in serum because
they are localized to the site of infection.11 The current standard of care involves
arthrocentesis when an infection is suspected, where the joint is aspirated using a syringe
to collect synovial fluid from the joint capsule and analyzed for white blood cell count and
differential,12,13 crystals, Gram stain, and culture.14,15 In addition, the synovial fluid is
composed of infection biomarkers such as glucose,16 low pH/high lactate concentrations,17–
19

C-reactive protein,20–22 interleukins,23,24 interferon‐γ,10 leukocyte esterase,25,26 α-

defensin,20,27,28 and cathelicidin29 which can be useful for the diagnosis of infection.
Several studies show that in a well-mixed synovial joint fluid and during infection,
synovial fluid pH decreases from 7.5 in aseptic conditions to 6.7-7.0.16,30 In addition, pH
correlates strongly with white blood cell count,30,31 as well as lactic acid,18,32 both of which
are used to detect prosthetic joint infection: typical infection thresholds for synovial white
blood cell count is >3000 cells/µL (sensitivity of 84% and specificity of 93%)33 and for
lactic acid is >8.3 mmol/L (sensitivity of 71.4% and specificity of 88%).23 Acidosis results
from production of acidic products as a result of metabolic activity of bacterial cells (e.g.
short chain fatty acid by-products) and immune cells (e.g. lactic acid and carbon dioxide
from anaerobic glycolysis activity).15,34,35 However, arthrocentesis is not practical for
routine screening or serial monitoring during treatment, since the procedure is painful and
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needs to be performed by a radiologist under fluoroscopic or ultrasonic image guidance.36,37
In addition, improper/inadequate fluid aspiration or delayed measurement can confound
analysis38,39 and reported complications include allergic reactions to the local anesthetic or
the contrast agent used.36 Numerous detection methods have been studied to measure pH
in tissue during infection using imaging methods such as positron emission tomography
(PET) and magnetic resonance imaging (MRI).40,41 However, the currently available
diagnostics have not been used to detect pH in synovial fluid and they lack sufficient
sensitivity, specificity, and simplicity for early and effective noninvasive detection of
infections.
We report the development of an X-ray based sensor inserted during surgery that
could be used as a potential X-ray imaging functional chemical sensor for noninvasive
detection and studying of implant infection (Figure 1b). Physicians routinely use X-rays
following prosthetic joint surgeries to image anatomy and associated pathologies because
they penetrate through deep tissue and show contrast between air, soft tissue, bone, and
metal hardware.42,43 However, X-rays are usually blind to local biochemical information
such as pH and insensitive to small biomechanical changes. Our sensor is the first sensor
that is being developed to measure synovial fluid, radiographically. The sensor uses a
polyacrylic-acid based hydrogel44,45 with pH-dependent swelling to report pH in a plain
radiograph via measuring the position of a radio-dense tantalum bead in the hydrogel
relative to a radiodense scale next to the hydrogel (see Figure 2.1). The sensor is attached
to or integrated into the prosthesis prior to surgical implantation and would provide a
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painless, rapid, non-invasive, inexpensive, measurement using plain radiographs already
acquired as part of the current standard of care.

Figure 2.1: a) Radiograph of a patient with a prosthetic hip. b) Schematic diagram of
prosthetic hip with attached synovial pH sensor. Inset shows the mechanism of pH sensing.
Reproduced with permission from Reference 1, Advanced Functional Materials, 2021.

2.3. Materials and Methods
2.3.1. Materials
Acrylic acid 99% (Sigma, USA), n-octyl acrylate containing 400 ppm 4-methoxyphenol as
inhibitor (Scientific Polymer Products, USA), anhydrous poly(ethylene glycol) diacrylate
with average Mn 700 (Sigma, USA), 2-oxoglutaric acid (Wako Pure Chemical Industries
Ltd, USA), N,N-dimethyl formamide (Sigma, USA), phosphate buffered saline (Sigma,
USA), reagent alcohol (VWR, Radnor, PA), reference standard pH buffers ranging from 2
to 11 (VWR Analytical, USA) were used as received. Bovine synovial fluid was obtained
from Lampire Biological Labs, Pipersville, PA. Tantalum beads (0.394 mm diameter) were
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purchased from X-Medics, Frederiksberg, Denmark. Tungsten wire (diameter 0.26 mm)
was purchased from McMaster-Carr, US. The polycarbonate casings for the sensor were
machined by the Clemson University Machining and Technical Services. The sensor was
attached to the prosthesis using Loctite Superglue Gel Control (Rocky Hill, CT).

2.3.2. Synthesis of pH sensing hydrogel
The hydrogel was prepared by free-radical co-polymerization of acrylic acid and n-octyl
acrylate as the monomers, poly(ethylene glycol) diacrylate (M n 700) as the crosslinker and
2-oxoglutaric acid as the photoinitiator, with dimethylformamide as the solvent. The photopolymerization reaction was performed under an inert nitrogen atmosphere (Cleatech
2100-4-C glove box, Cleatech, LLC, Santa Ana, CA, with attached oxygen analyzer
maintained at 0 % oxygen level and a Cleatech A21-HM-OA Nitrogen Purge controller),
using UV irradiation (365 nm) from both sides of the reaction cell at a temperature of
approximately 45 °C. The resulting polyacrylic acid-based hydrogel films were washed
with 70% ethanol to remove any residual monomers, N,N-dimethyl formamide and hydrate
the hydrogel. The hydrogel was washed daily for at least 5 days to ensure removal of
unreacted monomers and initiators in the hydrogel film. Hydrogel samples of length were
transferred to pH 7.4 phosphate buffered saline (PBS).

2.3.3. Calibration of pH sensing hydrogel
Hydrogel samples were fully immersed in a series of standard pH buffers ranging from 2
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to 11 at room temperature (25 °C) and their size was measured photographically using the
NIH ImageJ software package. Bovine synovial fluid sample (Lampire Biological Labs,
Pipersville, PA) was adjusted from pH 5-9 and the response of the hydrogel sensor to pH
changes in the bovine synovial fluid was studied. Prior to the experiment, the bovine
synovial fluid was thawed and degassed by incubating in a water bath at 60 ˚C for 1 hour.
The pH of the bovine synovial fluid was then adjusted by the addition of 1 M HCl, or 1 M
NaOH as needed to reach the desired pH to be tested. The pH was measured using a pH
meter (Orion™ PerpHecT™ ROSS™ Combination pH Electrode, Thermo Scientific,
Beverly, MA). Hydrogel samples were then placed in bovine synovial fluid of each pH and
images were taken using camera.

2.3.4. Response rate of pH sensing hydrogel
The hydrogel sensor was alternately placed in bovine synovial fluid adjusted to pH 6.5 to
pH 7.5 (by the addition of 1 M HCl, or 1 M NaOH as needed) and images were taken. The
size of the hydrogel sensor can be determined with NIH ImageJ software.

2.3.5. Synovial fluid pH sensor fabrication
Hydrogel with a radiodense tantalum bead (0.394 mm diameter) embedded in one end was
pinned to the polycarbonate casing/ groove with a tungsten wire (diameter 0.26 mm). The
groove with the hydrogel was then filled with pH 7 standard buffer and the hydrogel was
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allowed to equilibrate at pH 7. Then, another tungsten wire was glued to the outside of the
casing using commercially available adhesive to mark the pH 7 reference position (Loctite
Superglue Gel Control, Rocky Hill, CT).

2.3.6. X-ray imaging of synovial fluid pH sensor on prosthetic hip implant
In order to determine the best position to place the sensor on the implant, the sensor (the
polycarbonate casing containing the hydrogel with radiopaque markers) was placed on a
prosthetic hip implant at different locations and X-ray images were taken at 80 keV using
projection X-ray imaging/ plain radiography (NEXT Equine DR II portable digital
radiography system, Carlsbad, CA, with a battery powered veterinary X-ray generator,
Oberhausen-Germany). The sensor was then placed at the neck of the prosthesis and tested
at pH 6.5 and 7.5 by changing the solution in the groove and allowed to equilibrate in the
solution for 30 minutes, after which an X-ray image was taken, and length measurements
were analyzed using NIH ImageJ software.

2.3.7. Interobserver reliability of synovial fluid pH sensor
Fifteen radiographs of sensor attached to the prosthetic implant in bovine synovial
fluid between pH 6 and 8.5 were given to five observers. The order was randomized and
each observer measured length of the sensor for each radiograph using NIH ImageJ
software. The length measurements were then converted to pH using the developed
calibration graph of length of hydrogel versus pH. 2.4.
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Results and Discussion
2.4.1. Synthesis of pH sensing hydrogel
Hydrogels are a group of water-swollen polymeric materials that exhibit reversible
volume changes in response to environmental changes such as changes in pH, temperature,
electric field and light.46–48 These stimuli-responsive hydrogels are commonly used as
smart soft materials in the fabrication of sensors and drug delivery systems. Since we are
interested in measuring pH, we selected a hydrogel based on polyacrylic acid due to its pH
response and high biocompatibility (e.g. used in diapers, cosmetics, and medical
implants).49–51 Polyacrylic acid is reported to be stable, nontoxic, non-inflammatory, and
with the ability to mimic tissues surrounding bone. Polyacrylic acid coatings have been
previously studied for use in preventing corrosion on titanium and other metallic
implants.52 Polyethylene glycol (PEG)/polyacrylic acid devices have also been investigated
in a rabbit model for use as corneal implants.53 The hydrogel was prepared by free-radical
copolymerization of monomers acrylic acid and n-octyl acrylate (which shifts the effective
pKa and calibration curve closer to neutral pH).44,45,54 The resulting polymer chains were
crosslinked using poly(ethylene glycol) diacrylate as crosslinker and 2-oxoglutaric acid as
photoinitiator. Photopolymerization in an inert atmosphere under UV light (365 nm)
produced the hydrogel films used for the sensor fabrication.
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2.4.2. Calibration of pH sensing hydrogel
In order to determine the pH response and effective pKa of the hydrogel films, a pH
calibration was carried out by placing the hydrogel in a series of pH buffer standards (VWR
Analytical, USA) and measuring its length. The results showed that the swelling behavior
of the polyacrylic acid-based hydrogel is highly dependent on the pH of the surrounding
medium due to the presence of carboxylic acid side groups (Figure 1). At low pH, the
carboxylic acid (–COOH) groups in the polyacrylic acid hydrogel chains of the network are
neutral. At high pH, the carboxylic acid groups get deprotonated and become negatively charged
carboxylate ions (–COO−).55 The increased ionization in more alkaline environments causes the
hydrogel to swell due to a combination of increased electrostatic repulsions between bound
charges on the polymer chains and increased osmotic pressure.44,45 A radiodense tantalum
bead and a metal wire were embedded in the two ends of the hydrogel to monitor the change
in length of the hydrogel sensor in response to pH via plain radiography.
The calibration curve was fitted to a modified Henderson–Hasselbach equation with the
degree of swelling assumed to be proportional to the fraction of negatively charged
(deprotonated) carboxyl groups (α) (equation 2.1 and 2.2). In the equations, pKa is the acid
dissociation constant of polyacrylic acid, prefactor n is added to account for the distribution
of dissociation constants, and α is the fraction of negatively charged (deprotonated) carboxyl
groups, de is the equilibrium diameter of hydrogel, dmax and dmin are the maximum and minimum
diameters of the hydrogel, respectively. From the calibration graph in Figure 2.2, the pKa of the
synthesized hydrogel was 5.56 and n value of 2.50. Similar results were observed when the
experiment was repeated in bovine synovial fluid in the physiologically relevant pH.
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𝛼

𝑝𝐻 = 𝑝𝐾𝑎 + 𝑛 log 1−𝛼
𝑑𝑒 =

𝑑𝑚𝑎𝑥 × 10(𝑝𝐻−𝑝𝐾𝑎 )/𝑛 + 𝑑𝑚𝑖𝑛
1+ 10(𝑝𝐻−𝑝𝐾𝑎 )/𝑛

(2.1)
(2.2)

Figure 2.2: pH response of the polyacrylic acid hydrogel pH 2 to 11. Reproduced with
permission from Reference 1, Advanced Functional Materials, 2021.

2.4.3. Response rate of pH sensing hydrogel
The sensor response time and reversibility were studied in bovine synovial fluid by
adjusting the synovial fluid to pH 6.5 and 7.5, the pH range relevant to infection. As seen
in Figure 2.3, the sensor showed a high reversibility in bovine synovial fluid under repeated
cycles and no significant drift. The lack of drift (here and also after incubation in synovial
fluid for days) is expected because it is an equilibrium-based sensor and is in contrast to
most pH electrodes, which are highly sensitive to surface biofouling because they measure
non-equilibrium current through the surface. The results in bovine synovial fluid were also
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similar to that observed in buffers. We also previously showed that the same hydrogel
swelling was minimally affected by physiological variation in buffer and tryptic soy broth
bacterial culture ionic strength, temperature (25-40 ˚C), or long term incubation in a highly
oxidative environment with hydrogen peroxide and copper ions.56

Figure 2.3: Reversibility of polyacrylic acid hydrogel in bovine synovial fluid cyclically
varied between pH 6.5 and 7.5. Lines show fit to an exponential (t=30 min). Reproduced
with permission from Reference 1, Advanced Functional Materials, 2021.

The swelling and deswelling cycles were fit to an exponential decay and had a time
constant of around 30 minutes. Compared to buffer solutions, synovial fluid rates were
slower likely due to increase in viscosity; however, since the lateral diffusion rate scales
with the diameter squared, we reduced the diameter by half and found 30-minute response
time. Although many physiological responses will be slow, on the order or hours or days,
a faster rate is important for facilitating in vitro experiments; 30-minute rates would be
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appropriate for studying acute changes (e.g., after a glucose spike especially in diabetic
patients), while slower response rates find average response.

2.4.4. Synovial fluid pH sensor fabrication
In order for the hydrogel length changes to measured radiographically, radiopaque
markers were used to mark the two ends of the hydrogel. Since hydrogels are fragile, in
order to prevent damage for in vivo studies, a polycarbonate casing was used to hold the
hydrogel (Figure 2.4). Polycarbonate is widely used in biomedical applications such as in
blood oxygenators and blood reservoirs in cardiac surgery products, filter cartridges for
renal dialysis and surgical instruments due to its biocompatibility, glass like clarity, high
strength, and impact resistance.57,58 A hydrogel with a radiopaque tantalum bead at one end
was pinned to the polycarbonate casing using a radiopaque tungsten wire. After
equilibrating the sensor at pH 7, the position of the hydrogel at pH 7 was marked by another
piece of tungsten wire. The sensor is therefore composed of the pH responsive hydrogel,
radiopaque markers (pinning wire, reference wire and bead at end of hydrogel) and the
polycarbonate casing.
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Figure 2.4: Photograph of sensor with hydrogel and radiopaque markers.

2.4.5. X-ray imaging of synovial fluid pH sensor on prosthetic hip implant
The sensor (hydrogel with radiopaque markers in the polycarbonate casing) was
attached to the neck of the hip prosthetic implant (Figure 2.5a). so that the sensor would be
in contact with synovial fluid but away from pressure bearing surfaces. The radiographs
clearly showed the implant and the sensor position (Figure 2.5b). The change in length in
response to pH can be determined from the X-ray images by measuring the length between
the tantalum bead and the radiopaque wire. At pH 7.5, the bead could clearly be seen
passing the pH 7 marker wire, while at pH 6.5, the bead was clearly before the marker
(Figure 2.5c).

Figure 2.5: a) Photograph of hip prosthesis with attached pH sensor. b) Radiograph of hip
prosthesis with attached pH sensor. c) Sensor on implant at 7.5 and 6.5 in bovine synovial
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fluid. Reproduced with permission from Reference 1, Advanced Functional Materials,
2021.

2.4.6. Interobserver reliability of synovial fluid pH sensor
To assess inter-observer variability, five-observers were given a randomized series of 15
radiographs in bovine synovial fluid between pH 6 and 8.5 (Figure 2.6a). Each observer
measured bead position and distance between pin markers as a calibrant; the relative length
and a prior-data calibration curve was used to determine “measured pH.” Plot of measured
pH versus actual pH is shown in Figure 2.6b. The observers largely agreed with each other
and with the values used in the initial calibration fit except at pH 6, where there was a 0.22
pH unit systematic error. Specifically, the average interobserver precision was 0.03 pH
units and interobserver accuracy (root mean square difference from calibration fit) was
0.08 pH units (including the pH 6.0 data).
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Figure 2.6: a) Randomized series of 15 radiographs in bovine synovial fluid between pH
6 and 8.5 given to five observers. b) Measured pH versus actual pH (reproduced with
permission from Reference 1, Advanced Functional Materials, 2021).

2.4.7. Limitations
The study has several limitations especially with respect to ultimate clinical
application. First, it was performed only in ex vivo bovine synovial fluid with added HCl
and NaOH to adjust the pH (and previously in buffers and bacterial cultures with varying
temperature, sodium chloride concentration, and oxidative environment).56 The in vivo
response may be different, especially after long term implantation.
Second, the experiment was performed without tissue and clothing, and with a
device at a single orientation, the presence of tissue and orientation mismatch may affect
the resolution. That said, the bead position is measured relative to a scale on the device
which normalizes for changes in angle. We have consistently observed ≈50–100 μm
resolution on several port- able X-ray systems (C-arm and portable X-rays) and with
several different devices (pH sensor on orthopedic plate in cadaveric tibia, 56 orthopedic
tibial plate bending indicator,59 orthopedic screw bending sensor,60 and a fluidic plate
bending sensor).61 This resolution appears to be mostly limited by the X-ray pixel
resolution rather than device or sample. Most clinical standing X-rays are taken using
equipment that includes anti-scatter grids which give better images than the equipment we
are using. Additionally, the sensor resolution could be increased in future by making the
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sensor longer, adding mechanical gain,62 using computer vision algorithms to estimate bead
position in place of manual measurements, or changing composition.63,64
Third, although there have been many infection studies measuring white blood cell
counts and synovial lactate con- centration, which correlate with pH, there have only been
a few studies which directly measured pH in synovial fluid after arthrocentesis,30,32 in part
because of pH drift if fluid is improperly stored.30,38 Consequently, the sensitivity and
specificity of pH would need to be evaluated clinically, especially compared to
inflammation from aseptic loosening (which is also interesting but would be treated
differently).15,65 Moreover, the threshold and required resolution would depend upon the
application, for example in early screening versus confirmation or monitoring.
The developed implantable sensor is expected to remain inside the body
indefinitely. Two potential concerns regarding long term implantation involve potential
health risks from any toxic degradation products and effect on long-term performance of
the sensor. For the development of the sensor, we have selected materials that are designed
for long-term implantation. Tantalum, which is used as a bead in the sensor to deter- mine
the length changes of the hydrogel, can be toxic if large volumes in the form of
microparticles are inhaled or when injected as an intraperitoneal injection as a chloride salt
in rats (LD50 of 38 mg/kg body weight).66 However, the bead used in the sensor is smooth,
does not dissolve and has excellent anti-corrosion properties due to the presence of the
stable tantalum oxide protective film formed on the surface of the metal. 67,68 Tantalumbased materials have been widely used in clinical applications as radiographic markers, in
joint implants, reconstructive surgery, and in dental applications.67,69 Tantalum containing
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medical implants left in the body over long periods have been reported with no adverse
health effects.70 The polyacrylic acid based hydrogel which responds to pH, is expected to
have very low degradation as well, thus minimizing the release of any toxic products.
Acrylic acid polymers are widely used in drug delivery, biosensors, membrane and
separation devices due to their biocompatibility and extended lifespan. 46,71 Even though
shorter chain length acrylates can degrade and be excreted easily,72,73 the hydrogels with
their crosslinked polymer networks such as this, is expected to be highly resistant to
degradation within the lifetime of the patient.74,75
For all implanted chemical sensors, sensor fouling would affect the performance of
the sensor, in vivo.76,77 Fouling is considered less of a concern for an equilibrium sensor as
described here, although build-up could slow diffusion and affect the response rate. No
fouling effect on the sensor calibration curve, response rate, or sensor degradation was
observed in solutions of tryptic soy broth bacterial cell culture, bovine synovial fluid,
bovine serum, highly oxidative hydrogen peroxide, and copper ion medium, or storage in
pH 7 buffer.56 Several studies using polyacrylic acid-based hydrogels also demonstrated
the stability of these materials in vivo. However, modifications can be made to the sensor
to improve the lifetime by encasing the sensor and fluid in a carbon dioxide permeable
membrane such as polydimethylsiloxane, which is impermeable to aqueous molecules.78,79
To better address these issues, we are planning future studies ex vivo in patient samples
and in vivo in total hip arthroplasty sheep studies. We also plan to alter the hydrogel
composition (e.g., using enzymes,80 antibodies,81,82 and selectively permeable
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membranes)78,83 to detect other biomarkers of infection, such as glucose,80,84 carbon
dioxide,32 and alpha-defensin27,28 levels.
Physicians diagnose PJI using multiple lines of evidence as mentioned above and a
pH sensor to be useful, but values near the threshold around pH 7.1 may be equivocal,
particularly in differentiating septic infection from aseptic inflammation. Ongoing
antibiotic treatment may also lower pH response and there may be differences among
microbial species. Thus, pH measurements will not always avoid arthrocentesis or other
imaging techniques. Nonetheless, advantages of the sensor compared to synovial fluid
analysis lie in simplicity, speed (radiographs already routinely acquired), and more reliable
immersion in synovial fluid with no risk of dilution or drift between fluid removal and
analysis, and easier repeated analysis.
2.5. Conclusions
In summary, we describe the first implantable sensor that measures synovial fluid
pH using plain radiography. The sensor has a linear response and repeatable response
within 30 min in the range of pH 6.5 and 7.5 in bovine synovial fluid solutions and a pH
accuracy of 0.08 pH units. The approach is rapid, non-invasive, and uses X-rays that are
already taken as part of the postoperative standard of care. Thus, the developed sensor
could be used as a potential X-ray imaging functional chemical sensor to detect postsurgery hip infections.
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CHAPTER THREE
X-RAY BASED SYNOVIAL FLUID CARBON DIOXIDE SENSOR FOR THE
EARLY DETECTION OF PROSTHETIC HIP INFECTIONS
3.1. Abstract
Prosthetic hip infections are a common complication of hip surgeries and early
diagnosis of these infections are extremely challenging. We developed a novel implantable
carbon dioxide sensor for non-invasive early detection and monitoring of hip infections by
measuring synovial fluid carbon dioxide levels, radiographically. The sensor is based on a
pH responsive hydrogel as the sensing material covered with a carbon dioxide permeable
membrane. At high carbon dioxide levels, the pH would decrease resulting in shrinking of
the polyacrylic acid hydrogel. The length changes of the hydrogel can be monitored using
plain radiography by measuring the movement of the tantalum bead with respect to the
metal wire. It is expected for the sensor to have a longer lifetime compared to the pH sensor
due to the encapsulation of the sensor and fluid in a carbon dioxide permeable membrane
which is impermeable to aqueous molecules. The sensor shows a clear response in the
range of 15-115 mm Hg carbon dioxide, independent of the external solution pH. In
summary, the sensor is useful for noninvasive early detection of prosthetic hip infections
by measuring carbon dioxide levels in synovial fluid.
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3.2. Introduction
One of the leading causes of failure following joint replacement surgery are postsurgery infections with an incidence of about ~0.5-2% of total hip replacement surgeries.1,2
The complications of post-surgery infections involve prolonged hospitalization, multiple
operations, significant permanent deformity, or loss of the implant.1,3,4 In the elderly, it
may result in a higher incidence of mortality. Risk factors for infection include obesity,
diabetes mellitus, rheumatoid arthritis, exogenous immunosuppressive medications, and
malignancy.2,5–7
Infection associated with prosthetic joints are caused by microbial contamination
which may occur during surgery or hematogenously due to microbial spread through
bloodstream from a distant focus of infection.8–10 Most cases of hip infections are caused
by staphylococci species such as Staphylococci aureus and coagulase-negative
staphylococcus species.1,11–13 The prosthetic hip joint provides a surface for the attachment
of microbial cells.12,14 The microbes grow to form a monolayer, which later develops into
a microcolony and eventually a biofilm is formed where the microbes are enclosed in a
polymer matrix.15–17 The biofilm protects the microbes from conventional antimicrobial
agents and the host immune system, thus resulting in increased resistance to antibiotics and
host immune responses.18–20 Generally, due to low oxygen levels, anaerobic fermentation
in the biofilm leads to local depletion of nutrients and accumulation of metabolic waste
products such as lactic acid, citric acid, carbon dioxide, propionic acid, glycerol, ethanol,
etc., within the biofilm (Figure 3.1a).15,21,22 Studies of synovial membrane metabolism have
been used to study the mechanism of lactic acid formation in the joints as reflected by

1

partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), pH and lactic
acid in synovial fluid effluents of septic joints from patients. 23–26 The studies showed a
decrease in pO2 was accompanied by a decrease in pH and an increase in pCO 2 and lactic
acid concentrations.24,27,28 In a study by Treuhaft and McCarty, a sharp rise in pCO2 and
lactate levels and decrease in pH was observed in samples with pO 2 levels lower than 27
mm Hg.24 The correlation between pH and pCO2 is shown in Figure 3.1b.24 The rise in
lactate may be due to the changeover of local tissues from mainly aerobic to anaerobic
metabolism in anoxic conditions resulting in decrease in pH. An inverse relationship
between synovial lactic acid levels and glucose was determined by Lund-Oleson23 as a
result of metabolism of glucose to pyruvic acid, followed by conversion to lactic acid under
anaerobic conditions as shown in Figure 3.1a. Therefore, due to the poor removal of
products, the pCO2 levels would be higher during infection and can be used as a biomarker
of infection.

Figure 3.1: (a) Schematic diagram of cellular glucose metabolic pathways resulting in
acidic metabolites. (b) Carbon dioxide partial pressure (pCO2) of 55 joint fluids plotted

2

against pH values of the same fluid (reproduced with permission from Reference 24,
Arthritis & Rheumatology, 1971).
Different methods of carbon dioxide sensing have been developed based mainly on
optical methods. A common technique developed for sensing carbon dioxide include use
of optodes (an optical fiber with a chemical sensing layer at tip), however it requires
advanced readout equipment which can be expensive and may not be easily available in
the medical settings.29–33 Different types of solid electrolyte sensors for carbon dioxide
detection have been developed which uses potentiometry, amperometry, and
conductometry which are mostly suitable for measuring low pCO 2.33–35 Carbon dioxide
sensors have been developed that are based on the Severinghaus principle,36 where carbon
dioxide diffuses through a gas permeable membrane into an electrolyte solution resulting
in a pH change which can be measured using various methods. 33 The pH measurements
were originally carried out using

glass electrode however it is not suitable for

miniaturization, and other alternative methods including metal oxide electrodes, solvent
polymeric membrane electrodes require reference electrodes which may suffer from
drift.33,37
We are developing a carbon dioxide sensor for early detection of prosthetic joint
infections based on a pH responsive hydrogel as the sensing material. Arthrocentesis
(synovial fluid aspiration) is commonly used to detect/confirm infection when suspected
from clinical examination and radiology.38,39 However, the method is highly sensitive to
conditions of fluid aspiration/storage, specifically, carbon dioxide may escape, resulting in
pH drift.40,41 While arthrocentesis is performed if infection is indicated, it is impractical or
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contraindicated for screening or serial prosthetic joint infection measurements to monitor
treatment because it is performed by a radiologist under fluoroscopy or ultrasound
guidance which adds cost and scheduling issues; the procedure is painful, can induce tissue
damage and allergic reaction to anesthetics or injected X-ray contrast agent used to confirm
needle placement; complications are reported in 1-5% of cases; there is a very small but
concerning risk of infecting a previously aseptic joint (with associated liability if test was
not indicated).42,43 Thus, noninvasive measurements of synovial fluid carbon dioxide
measurements would be very helpful for early detection when more conservative
treatments are often successful, and for monitoring treatment until eradication. Previously,
we have developed a hydrogel-based pH sensor to measure pH of synovial fluid for the
early detection of hip infections using X-ray imaging.44 Even though no fouling effect on
the sensor calibration curve, response rate or sensor degradation was observed in solutions
of tryptic soy broth bacterial cell culture, bovine synovial fluid, bovine serum, highly
oxidative hydrogen peroxide and copper ion medium, or storage in pH 7 buffer,45
biofouling maybe a potential concern for an indwelling sensor. We have modified the pH
sensor to determine carbon dioxide levels in synovial fluid with the added advantage of
improved lifetime by encasing the sensor and fluid in a carbon dioxide permeable
membrane which is impermeable to aqueous molecules.46 The pH-sensitive hydrogel is
placed in a sodium hydroxide solution enclosed by a carbon dioxide permeable membrane
and exposed to different carbon dioxide concentrations. Higher carbon dioxide levels
would result in decrease in pH of the solution, resulting in a change in size of the hydrogel,
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which can be measured by X-ray radiography using the distance between the tantalum bead
and the tungsten wire.33,36 Schematic representation of the sensor is shown in Figure 3.2.

Figure 3.2: Schematic diagram of the hydrogel-based sensor to measure carbon dioxide
levels.
3.2.1 Theory of synovial fluid carbon dioxide sensor
The sensor is covered with a gas-permeable membrane, which allows diffusion of
CO2 into the buffer solution without the interference of other liquids. The CO2 that diffuses
in will acidify water as represented in the following equilibria:
KCO2 = 3.38 × 10-2

CO2(g) + H2O(l) ⇌ H2CO3(aq)
H2CO3(aq)

⇌

H+(aq) + HCO3-(aq)

K1 = 10-6.352

HCO3-(aq)

⇌

H+(aq) + CO32-(aq)

K2 = 10-10.329

where KCO2 is the Henry’s law constant and K1 and K2 is the first and second dissociation
constants of H2CO3. The pH was calculated for different carbon dioxide levels (PCO2) and
plotted as shown in Figure 3.3 for distilled water and 1 mM NaOH. As seen in the graph
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and according to Severinghaus et al., the addition of a base to water will double the pH
response to CO2. Therefore, the electrolyte solution used for the experiment is sodium
hydroxide.

8.5
8
7.5
7

6

pH

6.5

5.5
5
4.5
1.00E-04

1.00E-03
1.00E-02
PCO2 (atm) [log scale]

4
1.00E-01

Figure 3.3: Calculated pH versus PCO2 in distilled water and 1 mM NaOH.

3.3. Materials and Methods
3.3.1. Materials
Acrylic acid 99% (Sigma, USA), n-octyl acrylate containing 400 ppm 4-methoxyphenol as
inhibitor (Scientific Polymer Products, USA), anhydrous poly(ethylene glycol) diacrylate
with average Mn 700 (Sigma, USA), 2-oxoglutaric acid (Wako Pure Chemical Industries
Ltd, USA), N,N-dimethyl formamide (Sigma, USA), phosphate buffered saline (Sigma,
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USA), reagent alcohol (Radnor, PA), reference standard pH buffers ranging from 2 to 11
(VWR Analytical, USA), Parafilm® M (Bemis Company, Inc., USA) were used as
received. Sodium hydroxide (Ricca Chemical Company, Arlington, TX) and acetic acid
(VWR Analytical, USA) was diluted as needed. Sodium hydrogen carbonate was
purchased form VWR Chemicals BDH, West Chester, PA. Tantalum beads (0.394 mm
diameter) were purchased from X-Medics, Frederiksberg, Denmark. Tungsten wire
(diameter 0.26 mm) was purchased from McMaster-Carr, US. The polycarbonate casings
for the sensor were machined by the Clemson University Machining and Technical
Services.

3.3.2. Synthesis of pH sensing hydrogel
The hydrogel was prepared by free-radical co-polymerization of acrylic acid and n-octyl
acrylate as the monomers, poly(ethylene glycol) diacrylate (M n 700) as the crosslinker, and
2-oxoglutaric acid as the photoinitiator, with dimethylformamide as the solvent. The photopolymerization reaction was performed under an inert nitrogen atmosphere using UV
irradiation (365 nm) from both sides of the reaction cell at a temperature of approximately
45°C. The resulting polyacrylic acid-based hydrogel films were washed with 70% ethanol
to remove any residual monomers, N,N-dimethyl formamide, and hydrate the hydrogel.
The hydrogel was washed daily for at least 5 days to ensure the removal of unreacted
monomers and initiators in the hydrogel film. Hydrogel samples of length ~10 mm was
transferred to pH 7.4 phosphate-buffered saline (PBS).
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3.3.3. Sensor response with time
For these experiments, the hydrogel was placed inside a tube open at both ends, one end
was covered with parafilm and 0.1 mM NaOH was added to the tube and the other end was
then sealed with parafilm. The tube was then immersed in a sodium bicarbonate solution
corresponding to 15 mm Hg dissolved carbon dioxide (dCO2) and allowed to equilibrate.
Then it was transferred to a bicarbonate solution corresponding to 115 mm Hg dCO2 and
images were taken, and the length of the hydrogels were measured using ImageJ software.
Dissolved carbon dioxide standards were prepared by dissolving sodium hydrogen
carbonate in deionized water to prepare a 1 M NaHCO3 solution which was diluted to yield
15 mm Hg and 115 mm Hg dissolved CO2 concentrations as given in Burke et al, 2006.47

3.3.4. Synovial fluid carbon dioxide sensor calibration
For these experiments, the hydrogel was placed inside a tube open at both ends, one end
was covered with parafilm and 0.1 mM NaOH was added to the tube and the other end was
then sealed with parafilm. Each tube was placed in a bicarbonate solution corresponding
to 15, 30, 45, 60, 76, 91, and 115 mm Hg dissolved carbon dioxide (dCO2) and images of
the sensors were taken after 24 hours, and the length of the hydrogels were measured using
ImageJ software. Dissolved CO2 standards were prepared by dissolving sodium hydrogen
carbonate in deionized water to prepare a 1 M NaHCO 3 solution which was diluted to yield
the desired dissolved CO2 concentrations as given in Burke et al, 2006.47
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3.3.5. Fabrication of synovial fluid carbon dioxide sensor
The hydrogel was pinned at one end to a polycarbonate groove with a tungsten wire, and a
radiodense tantalum bead (0.5 mm diameter) was embedded in the other end of the
hydrogel. The groove was filled with 0.1 mM NaOH solution, and the groove was covered
with parafilm at the top using commercially available adhesive (Loctite Superglue–Gel
Control).

3.3.6. X-ray imaging of synovial fluid carbon dioxide sensor on hip implant
The synovial fluid carbon dioxide sensor was placed at the neck of the prosthesis and an
X-ray image was taken (NEXT Equine DR II portable digital radiography system,
Carlsbad, CA, with a battery powered veterinary X-ray generator, Oberhausen-Germany),
and length measurements were analyzed using NIH ImageJ software.

3.4. Results and Discussion
3.4.1. Synthesis of pH sensing hydrogel and fabrication of injectable sensor
Hydrogels are networks of cross-linked hydrophilic polymers that can contain a
large amount of water.48–50 Hydrogels can undergo volume changes in response to changes
in stimuli such as pH, temperature, light, ion concentration or electric field.48,51 Hydrogels
are widely used in the biomedical field in tissue engineering, drug delivery, self-healing
materials, biosensors, and hemostasis bandages due to their increased biocompatibility,
tunable biodegradability, properly mechanical strength, porous structure.52–54 In addition,
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hydrogels are used as sensors and actuators, where the stimulus-sensitive hydrogel acts as
the sensing element and the transducer convert the swelling of the hydrogel to the optical
or electrical domain.55,56 Conductometric, amperometric, optical and mechanical methods
have been explored to measure hydrogel swelling. Several studies by Herber et al.
demonstrate the use of a pH responsive hydrogel as a sensing material and a pressure sensor
as a transducer to design carbon dioxide pressure sensor in the diagnosis for gastrointestinal
ischemia.33,55,57 The sensor was miniaturized in his last study,33 however, it does not discuss
a method of detection of carbon dioxide levels in vivo in the developed sensor.
We developed a similar carbon dioxide sensor that is based on the swelling/
deswelling properties of polyacrylic acid-based hydrogel, where we will be measuring the
length changes of the sensor in response to carbon dioxide levels, radiographically.
Polyacrylic acid was selected as a well-suited pH responsive material reported to be stable,
nontoxic, and non-inflammatory.58–60 Polyacrylic acid polymer coatings have been
previously studied for use in preventing corrosion on titanium and other metallic
implants.61 Polyethylene glycol (PEG) / polyacrylic acid devices have also been
investigated in a rabbit model for use as corneal implants.62 Polyacrylic acid hydrogels63,64
are responsive to pH and swells at high pH and de-swell at low pH, around its effective
acid dissociation constant (pKa) of 5.56.44 At high pH, the pendant carboxylic acid groups get
deprotonated and become negatively charged carboxylate ions (–COO−).58,65 Due to increased
electrostatic repulsions between bound charges on the polymer chains and increased osmotic
pressure the hydrogel swells at high pH.60,63 In contrast, at low pH the carboxylic acid groups
in the polyacrylic acid chains of the network do not have any charges resulting in less repulsions
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between the polymer chains and the hydrogel shrinks at low pH. Calibration of the pH hydrogel
sensor shows a linear response between pH 4-8, and an acid dissociation constant (pKa) of 5.56
when fitted to a modified Henderson-Hasselbalch equation with a factor (n=2.50) to account for
a spread in hydrogel pKa. Similar results were observed when the experiment was repeated in
bovine synovial fluid in the physiologically relevant pH. The sensor response fit well to an
exponential with a 30 min time constant, a linear response between pH 4-8, and 0.05 pH units
interobserver agreement. Thus, we expect the length changes in the hydrogel resulting from the
subsequent pH changes due to carbon dioxide variations in the synovial fluid can be detected
using X-radiography using the developed sensor.
The polyacrylic acid hydrogel used in the sensor design was polymerized by free
radical polymerization of the monomers, acrylic acid and n-octyl acrylate (n-OA);
crosslinker, poly(ethylene glycol) diacrylate (Mn 700); photoinitiator, 2-oxoglutaric acid,
with dimethylformamide (DMF) as the solvent. The photo-polymerization reaction was
performed under an inert nitrogen atmosphere using UV irradiation (365 nm) from both
sides of the reaction cell at a temperature of approximately 45 °C. The resulting polyacrylic
acid-based hydrogel films were washed with 70% ethanol to remove any residual
monomers, DMF and to hydrate the hydrogel. In the sensor design, for radiographic
measurements, the pH-responsive hydrogel with an embedded tantalum bead is pinned on
one end with a tungsten wire in a polycarbonate groove as shown in Figure 3.3.
Polycarbonate is used in a wide range of biomedical applications such as in blood
oxygenators and blood reservoirs in cardiac surgery products, filter cartridges for renal
dialysis and surgical instruments due to its biocompatibility, glass like clarity, high
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strength, and impact resistance.66,67 The groove is then sealed with parafilm as the carbon
dioxide permeable membrane in order to separate the hydrogel sensor from the external
solution in the sensor design (Figure 3.4). Parafilm is a waterproof, semi-transparent, flexible
film composed of a mixture of paraffin waxes and polyolefins which is permeable to gases like
carbon dioxide and oxygen.68 Recently, a study used drug loaded parafilm as a remotecontrolled thermoresponsive patch for dermal drug delivery.68 The gas permeability of parafilm
for carbon dioxide is 1200 cc/m² d at 23 °C and 50% relative humidity. The carbon dioxide
diffuses through the gas permeable membrane of parafilm into an electrolyte solution (0.1
mM NaOH) resulting in a change in pH (decrease in pH). Subsequently, in response to the
pH change, the hydrogel which is in contact with the electrolyte solution decrease in size.
Due to the presence of the radiopaque markers in the hydrogel, this change in length can
be measured using X-ray radiography.

Figure 3. 4: Image of sensor at carbon dioxide percentages 60 mm Hg (top) and 76 mm
Hg (bottom).
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3.4.2. Sensor response with time
The sensor response with time was measured by first stabilizing the sensor exposed
to PCO2 of 15 mm Hg and then transferring to a bicarbonate solution corresponding to PCO2
of 115 mm Hg, taking photographs of the sensor with time. Figure 3.5 shows the hydrogel
length with time. It could be seen that the sensor started to stabilize around 10 hours.

Figure 3.5: Hydrogel length vs time for the hydrogel-based carbon dioxide sensor.

3.4.3. Sensor calibration and selectivity
The hydrogel response to varying carbon dioxide levels is shown in Figure 3.6. The
sensor was placed in bicarbonate solutions of varying CO 2 levels and the length of the
hydrogel was measured. The change in length was calculated for each CO 2 level and
normalized to the change in length at 15 mm Hg CO2. As expected, the change in length
increased when CO2 levels increased from 15 to 115 mm Hg CO2.
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Figure 3.6: Calibration graph of hydrogel-based carbon dioxide sensor.

In order to test the selectivity of the sensor, initially the sensor (the hydrogel sensor
with radiopaque markers encapsulated in parafilm) was placed in different external
solutions of water, acetic acid, and sodium hydroxide and placed inside a cell incubator.
The sensor showed a clear response that is independent of external fluid. Since the sensor
is covered with a gas-permeable membrane, CO2 can diffuse into the buffer solution
without the interference of other liquids, whereas it is assumed that other gases present are
inert. Therefore, the response of the sensor to changes in pH and salt concentration can
only be attributed to the CO2.

3.4.4. X-ray imaging of synovial fluid carbon dioxide sensor
The synovial fluid carbon dioxide (hydrogel with radiopaque markers in the
polycarbonate casing covered with carbon dioxide permeable membrane) was allowed to
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incubate at 76 mm Hg (10% CO2) and 115 mm Hg (15% CO2) carbon dioxide levels. The
sensors were then imaged using X-ray radiography (Figure 3.7 a). The plain radiographs
clearly showed the positions of the radiopaque markers.
The synovial fluid carbon dioxide sensor was then attached to the neck of the hip
prosthetic implant (Figure 3.7b), so that the sensor would be in contact with synovial fluid
but away from pressure bearing surfaces. The radiograph clearly showed the implant and
the sensor position. The change in length of the sensor can be determined by measuring the
distance between tantalum bead and pinning wire, which were clearly visible on the
radiograph.

a
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b

Figure 3.7: a) X-ray image of synovial fluid carbon dioxide sensor at two different carbon
dioxide levels. b) Photograph of synovial fluid carbon dioxide sensor on hip prosthesis
(left), X-ray image of synovial fluid carbon dioxide sensor on hip prosthesis (right), with
the inset showing the zoomed image of the sensor with the radiopaque markers.

3.4.5. Limitations
With regard to clinical studies, the sensor performance needs to be determined ex
vivo and in vivo. It is expected that the encasing would protect the hydrogel sensor from
the pressure exerted by the surrounding tissue, thus having minimum effect on the
performance of the sensor. Therefore, similar values to the in vitro results are expected in
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the sensor performance in vivo, especially using a standing X-ray in place of a C-arm or
portable unit (where prior results were acquired but these lack anti-scatter grids).
A potential concern regarding implantable sensors is their biocompatibility and
stability in vivo. The materials used in the development of the sensor are biocompatible
and have shown long term stability in vivo. The polyacrylic acid-based hydrogels are
commonly used in drug delivery, biosensors, membrane and separation devices due to their
biocompatibility and extended life-span.54,59 They are expected to have very low
degradation since the crosslinked polymer networks are expected to be highly resistant to
degradation within the lifetime of the patient.58,69 Tantalum has excellent anti-corrosive
properties as a result of the stable tantalum oxide protective film formed on the surface of
the metal.70,71 Tantalum-based materials are widely used in clinical applications as
radiopaque markers and medical implants with no adverse health effects.70,72
The pH hydrogel used in the development of the sensor is equilibrium-based and
drift has not been observed after long term incubation in serum or even harsh oxidative
environments. The difference between the pH sensor and the developed carbon dioxide
sensor is that here the sensor is encapsulated with a carbon dioxide permeable membrane
which would avoid interaction with large molecules, while allowing carbon dioxide to
penetrate. It is expected this would dramatically improve sensor longevity in vivo. As an
alternative to the parafilm, polydimethylsiloxane (PDMS) film or tubing can be used as a
carbon dioxide permeable membrane. Compared to parafilm, PDMS is widely used as an
optically clear, flexible, inert, non-toxic, biocompatible material, and routinely used as a
biomedical implant material.73

17

3.5. Conclusions
A sensor with hydrogel composed of radiopaque markers sealed form the external
environment by a carbon dioxide permeable membrane shows a clear response to carbon
dioxide changes within a reasonable period of time. The hydrogel-based carbon dioxide
sensor responds well in the medical interesting range between 2 and 15% carbon dioxide
levels. The sensor was shown to be responsive selective to carbon dioxide due to the
presence of the carbon dioxide permeable membrane, which only allows gas molecules to
pass through. The sensor did not respond when exposed to acidic or basic external fluids,
showing its selectivity of variation in carbon dioxide. The developed sensor can therefore
be used for the measurement of carbon dioxide levels in synovial fluid.
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CHAPTER FOUR
AN X-RAY INTERROGATED FALLING BEAD SYNOVIAL FLUID VISCOSITY
SENSOR FOR EARLY DETECTION OF PROSTHETIC JOINT INFECTIONS
4.1. Abstract
Prosthetic joint infections are a major complication for patients undergoing joint
surgery. Available diagnostic tests are nonspecific to prosthetic joint infections and based
on serum or synovial biomarkers or culture methods which have their own disadvantages.
Synovial fluid viscosity is one of the parameters defining the rheology properties of
synovial fluid. during infection, the viscosity of synovial fluid decreases and it may be
useful as a diagnostic tool for prosthetic joint infections and may provide complementary
information regarding prosthetic joint infections. A falling bead synovial fluid viscosity
sensor was developed with the aim of using X-ray radiography to determine the rate at
which the bead falls which would be indicative of infection. The sensor consists of a
radiopaque bead moving in synovial fluid in a plastic tube with a scale and the rate of
movement of the bead can be measured by taking a series of X-ray images. Several
strategies for the viscosity sensor are discussed. A reference fluid containing fluid relevant
to clinically determined viscosity threshold was important way to compare and improve
viscosity resolution. The moving bead synovial fluid viscosity sensor has the potential to
be an important diagnostic tool noninvasive measurements of synovial fluid viscosity
measurements would be helpful in detection of prosthetic joint infections, early.
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4.2. Introduction
Prosthetic joint infections are infections involving the joint prosthesis and adjacent
tissue. Periprosthetic joint infection accounts for 25% of failed knee arthroplasties and 15%
of failed hip arthroplasties.1–3 Prosthetic joint infections remain a challenging complication
due to difficulties in diagnosis, unpredictability of occurrence, frequent need for prolonged
antimicrobial therapy and multiple surgeries.2,4,5 When infections are detected early (within
3 weeks of symptoms or 30 days of surgery), they can often be treated via antibiotics along
with surgical irrigation and debridement.2,6,7 After this time, however, treatment usually
requires implant removal followed by reinsertion of the implant after the infection is
eradicated. These revisions carry significant risks for patient mobility, other morbidities,
and mortality (5% 2-month mortality following prosthetic joint infection in 2015)8 as well
as staggering hospital costs. Direct costs of prosthetic joint infection treatment are around
$100,000 per episode,9 and lifetime treatment cost for a 65-year-old is an estimated
$390,806.10 Therefore, the ability to easily detect and monitor early infection during
healing would be key to reducing the need for costly revision surgeries.
Diagnosis of prosthetic joint infections is based upon a combination of clinical
findings, laboratory results from peripheral blood and synovial fluid, microbiological data,
histological evaluation of periprosthetic tissue, intraoperative inspection, and, in some
cases, radiographic results.4,11,12 There is no one test or finding that is 100% accurate for
prosthetic joint infection diagnosis. A set of clinical guidelines have being published by
the Musculoskeletal Infection Society (MSIS) for prosthetic joint infections which have
been useful in the diagnosis.13,14 The tests based on serum biomarkers currently in use are
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highly sensitive such as erythrocyte sedimentation rate (ESR), C-reactive protein levels
(CRP), and serum white cell counts (WBC),15–17 however they are less specific to prosthetic
joint infections since these markers are elevated in any type of inflammation or infection.18
Microbiological cultures require time and are not always successful in isolating the
infecting organisms and may result in false positive results.14 Molecular imaging
approaches like positron emission tomography (PET), single-photon emission computed
tomography (SPECT), or sophisticated magnetic resonance imaging (MRI) can detect
some relevant disease features but are expensive and not available everywhere. 19–21
Polymerase chain reaction (PCR) and gene sequencing also show promise but are not
routine at present.2,6,22 Radiographs are also routinely used in preclinical research and is
useful to screen for prosthetic loosening and fracture 20 but lacks sensitivity and specificity
to detect prosthetic joint infections.
Since systemic blood biomarkers of infection are often absent at early stages of
joint infections when the infection is nascent and localized, arthrocentesis (synovial fluid
aspiration) is commonly used to detect and confirm infection when suspected from clinical
examination and radiology.23–25 Aspirated synovial fluid samples are submitted for WBC
count and differential, crystal analysis, Gram stain, and bacterial culture cultures. The
methods suffer from low specificity (WBC count), or less sensitivity (Gram stain) long
analysis time (bacterial culture).12,22,26 Recently, there has been increasing interest in
potential use of synovial fluid biomarkers to achieve rapid diagnosis of joint infections.1,26–
28

The most frequently studied synovial fluid markers with high diagnostic utility in the

diagnosis of joint infections are synovial fluid C-reactive protein,25,29,30 leukocyte
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esterase,31–33 interleukins,17,34,35 and alpha-defensin.36–39 Currently, some biomarkers used
for prosthetic infection diagnosis include leukocyte esterase (using colorimetric test
strips)33,40 and alpha defensin (laboratory-based ELISA alpha-defensin test and the
commercially available SynovasureTM test kit).33,41,42 The immunoassay of aspirated joint
fluid for alpha-defensin molecules was shown to have high sensitivity and specificity for
diagnosing periprosthetic infection.28 However, a drawback of these tests for biomarkers
is that they can be performed only after synovial fluid is collected via arthrocentesis, which
is not practical for routine screening or serial monitoring during treatment due to high cost
of fluoroscopy and/or ultrasound guidance by radiologist, possible tissue damage or
allergic reaction from anesthetics or injected X-ray contrast agent, and possible potential
risk of infecting a previously aseptic joint.23,24 In addition, substantial dilution of synovial
fluid with saline or blood during collection (caused by the presence of a hemarthrosis or a
dry tap), results in poor quality synovial fluid specimens with diluted biomarkers,
decreasing the sensitivity of the laboratory testing.43,44 Thus, noninvasive screening of the
implantation site for detection of early infection is needed.
We are developing a synovial fluid sensor that can be attached to implants that will
enable measurement of synovial fluid viscosity in vivo using X-ray imaging technique.
Viscosity (a measure of a fluid’s resistance to flow) is one of the parameters defining the
rheology properties of synovial fluid. Viscosity of synovial fluid can be checked by
observing the length of the string formed as the syringe is pulled away from the slide where
normal fluid will form a string 5 to 8 cm in length before breaking.23,45 The main
constituents of human synovial fluid are proteins, lipids, and hyaluronic acid, which can
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have a significant effect on the rheological properties.46–48 Hyaluronic acid is the
macromolecule which provides synovial fluid with its viscoelastic properties. 47,49 It has
been shown that the concentration of hyaluronic acid in synovial fluid is in a close
relationship with synovial fluid viscosity.50 They showed that the synovial fluid acts as an
effective lubricant for the synovium membrane if it contains hyaluronic acid with an
intrinsic viscosity of about 4,000 mL/g or higher, and a concentration of greater than 0.5
mL/g. Studies show viscosity was lowered with low hyaluronic acid,51 and a negative
correlation was observed between total protein concentration and synovial fluid viscosity
properties.46,52
Previously, few studies have been done on using synovial fluid as a diagnostic
marker of prosthetic joint infections. Galandakova et al. found that synovial fluid viscosity
of patients with aseptic loosening differed from patients with osteoarthritis 53 and a study
by Fu et al.46 reported significantly lower viscosity in patients with prosthetic joint
infection (7.93 mPas, range 3.0-15.0) compared to the aseptic failure (13.11 mPas, range
6.3-20.4) as shown in Figure 4.1.46 They determined the optimal threshold value for
synovial fluid viscosity for the diagnosis of prosthetic joint infections to be 11.80 mPas,
and in their study synovial fluid viscosity outperformed CRP, ESR, and plasma D-dimer,
with a sensitivity of 93.33% and a specificity of 66.67%.46 The decrease in viscosity of the
fluid during infection may be due to degradation of hyaluronic acid in the synovial fluid
by proteolytic action of lysozymes released by polymorphonuclear cells or bacteria.45,46
Therefore, synovial fluid viscosity can be considered as a promising marker for the
diagnosis of prosthetic joint infections.
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Figure 4.1: Synovial fluid viscosity levels among patients with prosthetic joint
infections, aseptic loosening, and end stage osteoarthritis (reproduced with permission
from Reference 46, The Journal of Arthroplasty, 2019).

The synovial fluid viscosity sensor we are developing is based on the time it takes
for a radiopaque bead to move through the fluid in a tube (test sensor) and will be compared
with movement of a bead in reference tube with normal synovial fluid viscosity (reference).
Schematic representation is shown in Figure 4.2. The movement of the bead will be
visualized using a series of X-ray images in order to determine time. Radiology is used as
the preferred mode of visualization since it provides a rapid, noninvasive imaging
technique, available in almost all medical settings. During infection, due to lowering of the
viscosity of synovial fluid than normal, it is expected for the bead to fall faster in the test
sensor compared to the reference.46,54 Several sensor design approaches are discussed in
slowing down the dense radiopaque beads in order to obtain radiographs within a

35

measurable time and making use of wall effects from angle-dependent rolling on the tube
walls. The use of a reference fluid in a separate tube was also an important way to improve
viscosity resolution, especially near clinically determined viscosity thresholds. Thus,
noninvasive measurements of synovial fluid viscosity measurements would be helpful in
detection of prosthetic joint infections, early.

Figure 4.2: Schematic of falling bead synovial fluid viscosity sensor.

4.3. Materials and Methods
4.3.1. Materials
Glycerol was purchased from VWR Chemicals BDH®, West Chester, PA, polyethylene
glycol (PEG) with molecular weight 1000 and paraffin wax beads were purchased from
Spectrum Chemical Mfg. Corp, Gardena, CA. Plastic polyolefin tubes were purchased
from Sopby on Amazon.com, Inc. Tantalum beads (0.394 mm diameter) were purchased
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from X-Medics, Frederiksberg, Denmark. Tungsten microparticles were purchased from.
Bovine synovial fluid was obtained from Lampire Biological Labs, Pipersville, PA.

4.3.2. Preparation of glycerol and polyethylene glycol solutions of different viscosities
The glycerol/ water and polyethylene glycol/ water solutions of varying viscosities
corresponding to the physiological relevant values (~1-20 mPas) were prepared based on
literature. Glycerol solutions were prepared between 10, 30. 60, 70 weight %
glycerol/water for viscosities of 1.31, 2.50, 10.80 and 22.50 mPas, respectively based on
previously reported values.55,56 Polyethylene glycol (PEG) with molecular weight 1000
was used for the experiments with PEG and the solutions were prepared based on PEG
viscosity measurements by Gonzalez-Tello et al.57 The PEG/ water solutions used for the
experiments were between 10, 20, 30, 40, 50 weight % for viscosities of 5.2, 6.7, 9.2, 13.2,
and 24.4 mPas, respectively.

4.3.3. X-ray interrogated falling bead synovial fluid viscosity sensor based on radiopaque
tantalum bead
Glycerol solution (60 weight %) was prepared which correspond to viscosity of 10.8 mPas,
which is the average viscosity relevant to synovial fluid. A plastic tube (1.5 mm diameter)
sealed at one end with a binder clip was filled with the 60 weight % glycerol solution and
placed on a vertical surface with a scale attached to it. A tantalum bead (diameter: 0.394
mm) was allowed to freely fall through the solution and the time taken for the bead to fall
was determined by taking a video at 30 frames per second.
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In order to slow down the tantalum bead, a piece of Styrofoam was attached to the tantalum
bead using a small amount of commercially available adhesive (Loctite Superglue Gel
Control, Rocky Hill, CT). The bead was then allowed to freely fall through the glycerol
solution (60 weight %) solution and the time taken for the bead to fall was determined by
taking a video at 30 frames per second.

4.3.4. Angle dependence of tantalum bead movement in glycerol and bovine synovial fluid
A plastic tube sealed at one end was filled with the 60 weight % glycerol solution
(corresponding to ~10 mPas viscosity), a tantalum bead was added to it and the tube was
sealed at the open end (reference sensor). Another sensor was prepared by filling another
plastic tube with bovine synovial fluid, a tantalum bead was added to it and the tube was
sealed (test sensor). The sensor was attached to an inclinometer, which gives a measure of
the angle. The movement of the bead was measured at different angles in both the test and
reference sensor by taking videos for each at 30 frames per second.

4.3.5. X-ray interrogated falling bead synovial fluid viscosity sensor based on tungsten
microparticle encapsulated paraffin wax bead
A bead containing tungsten microparticles in paraffin wax was prepared as another strategy
to obtain a bead with the desired speed in viscosity relevant to synovial fluid. The bead
was prepared by encapsulating tungsten microparticles in melted paraffin wax and allowed
to cool. The bead was then allowed to freely fall through the glycerol solution (60 weight
%) solution and the time taken for the bead to fall was determined by taking a video at 30
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frames per second. In order to study the velocity of the bead at different viscosities, the
velocity of the bead was studied at physiologically relevant viscosities between ~1 and 20
mPas in both glycerol and PEG solutions. Solutions of glycerol were prepared between 1070 weight % glycerol/ water (corresponding to viscosities between 1.31 and 22.50 mPas,
respectively). Solutions of PEG were prepared between 10-50 weight% glycerol/ water
(corresponding to viscosities between 5.2 and 24.4 mPas, respectively). The bead was
allowed to freely fall through each solution and the time taken for the bead to fall was
determined by taking a video at 30 frames per second for each.

4.3.6. Testing the falling bead synovial viscosity sensor in an arm
The sensor was prepared by filling a plastic tube with 60 weight % glycerol solution
(corresponding viscosity 10.8 mPas). The tungsten microparticle encapsulated paraffin
wax bead added to the tube. The tube was then sealed on the open end and taped to a ruler
and the whole set up was taped to the arm to resemble the sensor in the elbow joint. The
arm was allowed to rest on a horizontal surface and the arm was moved by 45 degrees and
90 degrees and a video (at 30 frames per second) of the sensor was recorded for each. The
time taken for the bead to fall was determined from the video.

4.4. Results and Discussion
Synovial fluid is a viscous, straw colored, transparent fluid secreted into joint cavity
by the inner membrane of synovial joint (synovial membrane) and provides shock
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absorption, lubrication, and nutrition to adjacent articular cartridge. 23,49 Hyaluronic acid,
high-molecular-weight polymerized glycosaminoglycan, in synovial fluid is responsible
for its unique consistency and high viscosity of synovial fluid.47,50 Synovial fluid in animals
and humans is non-Newtonian with shear thinning properties (fluid whose viscosity
decreases with increasing shear rate).45,54 It is also elastic and thixotropic showing a yield
stress and in conditions of inflammation or infection, the flow properties of synovial fluid
changes. The fluid becomes less viscous, behaves more like a Newtonian fluid, and loses
its elasticity and thixotropy. The reason for decrease in viscosity during inflammation/
infection may be due to fragmentation of hyaluronate by the proteolytic action of
lysozymes released by polymorphonuclear cells resulting in decreased concentration of
hyaluronic acid and low viscosity of synovial fluid.47,58
The falling bead synovial fluid viscosity sensor aims to measures the rate/ time of
a falling bead in synovial fluid using X-ray radiography. The bead movement in a fluid is
based on Stokes’ Law, the drag force (f) on the metal sphere is proportional to the viscosity
of the fluid η, the radius r of the sphere, and the velocity (or speed) v of the sphere as:
f = 6πηrv

(4.1)

The ball approaches its terminal velocity through an exponential decay and then it
falls with a constant velocity when the gravitational force is equal to the buoyant force. As
shown in Equation 4.2, where ρb is the density of the bead, ρl is the density of the fluid
and g is acceleration due to gravity.
𝑣𝑓 =

2𝑟2 (𝜌𝑏− 𝜌𝑙 )𝑔

(4.2)

9η
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From the Equation 4.2, it can be derived that the terminal velocity of the bead is
indirectly proportional to viscosity of the fluid. For typical ball size and mass as used in
this sensor design, the time constant to reach terminal velocity is negligibly small) and can
be safely ignored. Other factors may affect the terminal velocity such as the object falling
near a boundary (like the wall of the container) moves more slowly than an object falling
far from a wall.59,60 Therefore, since there is a decrease in viscosity of synovial fluid during
infections, the bead would move at a slower rate during infections when compared to
normal and by the use of a radiopaque bead this movement can be visualized using X-ray
imaging. In the design of the falling bead synovial fluid viscosity sensor, the sensor needs
to able to see difference in viscosities 7 mPas or less since the clinically relevant values are
between 3.0-15.0 mPas.46 The sensor will be attached to prosthesis and the patient can be
asked to move the joint by 45 degrees or could roll patient lying on one side to the other
side. There should be at least 10 s between raising leg and taking X-ray (expect operator to
be +/- 1 s or more). Therefore, the bead velocity needs to be a minimum of 1 mm/s at 10
mPas for reliable measurements using X-ray.

4.4.1. X-ray interrogated falling bead synovial fluid viscosity sensor based on radiopaque
tantalum bead
For X-ray imaging of sensor, the bead needs to be radiopaque, or a radiopaque
marker should be attached to it. A sensor was prepared by filling a plastic tube with glycerol
adjusted to 10 mPas to mimic synovial fluid average viscosity (Figure 4.3a) and the time
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taken for a tantalum bead (diameter: 0.394 mm, density: 16654 kg m-3) was measured. The
time was too fast to be used for the measurements, therefore several strategies were used
to slow down the bead. Another sensor was prepared where a small piece of Styrofoam
was attached to the to the tantalum bead (diameter: 0.394 mm, density: 16654 kg m-3)
(Figure 4.3b) and its velocity in 10 mPas glycerol solution was measured. The attachment
of a less dense material like Styrofoam slowed the movement of the tantalum bead by about
0.67 cm/s.

Figure 4.3: (a) Tantalum bead (0.394 mm) moving inside a plastic tube in 10 mPas
glycerol solution, (b) Tantalum bead (0.394 mm) attached to Styrofoam moving inside a
plastic tube in 10 mPas glycerol solution.

4.4.2. Angle dependence of tantalum bead movement in glycerol and bovine synovial fluid
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The beads need to be slowed down so that at 10 mPas, it would need to travel 1 cm
in about at least 10 seconds (velocity of 1 mm/s). Another way to slow down would be to
measure the time taken for the bead to fall at different angles. For this, experiments were
carried out to determine the angle dependence on the velocity of the tantalum bead (0.394
mm diameter). The tantalum bead was allowed to fall through a bovine synovial fluid in
one tube, and a glycerol solution of 10 mPas viscosity in another tube (which acts as the
reference) at different angles using an inclinometer as shown in Figure 4.4.
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Figure 4.4: (a) Setup used to measure the angle dependence of the viscosity sensor
showing the tube with glycerol adjusted to 10 mPas and tube with bovine synovial fluid,
each containing a tantalum bead (0.394 mm diameter), (b) Velocity versus cosine angle for
the movement of tantalum bead in glycerol (10 mPas) and synovial fluid.

4.4.3. X-ray interrogated falling bead synovial fluid viscosity sensor based on tungsten
microparticles embedded in paraffin wax
Another strategy was to embed tungsten microparticles in paraffin wax (density of
~0.9 g/cm2) to make a bead (Figure 4.5a) and the velocity was measured. Results showed
adding paraffin works to slow down the velocity of the bead. A calibration graph was
prepared for the movement of the bead in both glycerol and polyethylene glycol (PEG)
(Figure 4.5b). The results showed a good linear curve of time vs. viscosity in both PEG
and glycerol solutions. However, viscosities by PEG or glycerol should completely overlap
and pass through the intercept, which can only be seen for PEG (glycerol about 0.1 seconds
high). A problem encountered was that when the bead was slowed down, at higher
viscosities the density comes into effect, and it started to float.
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Figure 4.5: (a) Bead made of tungsten microparticles embedded in paraffin wax moving
inside a heat shrink tube in 10 mPas glycerol solution, (b) Time for bead to travel 1 cm
versus viscosity for the tungsten particles in wax bead in glycerol and PEG adjusted to the
relevant viscosity.

4.4.4. Testing the falling bead synovial viscosity sensor in an arm
In order to show the proof of concept, the sensor was attached to arm and time
measurements for the bead to fall after moving the arm by 45 degrees and 90 degrees was
measured as shown in Figure 4.6. The sensor was prepared by filling a plastic tube with
glycerol adjusted to 10 mPas. The tube was then sealed on the open end and taped to a ruler
and the whole set up was taped to the arm to resemble the sensor in the elbow joint.
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Figure 4.6: The proof of concept of falling bead synovial fluid viscosity sensor attached
to an arm. The images show the movement of the bead after moving the arm by 45 degrees
(left) and after moving the arm by 90 degrees (right).

4.4.5. Limitations
Since the goal is to visualize the sensor radiographically, it is critical for the moving
bead to be radiopaque or have a radiopaque marker. Radiopaque materials have high
density, therefor ethe challenge is to slow the movement of the bead in order to be able to
take at least two X-ray images. Ideally, the bead travelling at a velocity of 1 mm/s in a 10
mPas viscous solution will enable us to obtain X-ray images and determine the time taken
for the movement of the bead. The tube needs to be made porous in order for the diffusion
of external synovial fluid. The sensor will need to be tested in different external solutions
to determine its selectivity and effect of surrounding medium.

46

4.5. Conclusions
A falling bead synovial fluid viscosity sensor was developed to determine infections early
during prosthetic joint infections by X-ray radiography. The sensor consists of a radiopaque
bead in synovial fluid inside a plastic tube with a scale and the rate of movement of the
bead can be measured by taking a series of X-ray images. A change in rate/ time taken for
the bead to fall will be an indication of infections due to decrease in viscosity during
infections. The tube with a reference fluid adjusted to the viscosity of the normal synovial
fluid will provide a way of comparing the viscosity, in vivo. Improvements need to be
made with regard to making the sensor be slow enough to enable X-ray imaging. The
moving bead synovial fluid viscosity sensor has the potential to provide noninvasive
measurements of synovial fluid viscosity measurements in detection of prosthetic joint
infections, early.

4.6. References
(1)

Deirmengian, C.; Kardos, K.; Kilmartin, P.; Cameron, A.; Schiller, K.; Parvizi, J.
Diagnosing Periprosthetic Joint Infection: Has the Era of the Biomarker Arrived?
Clin.

Orthop.

Relat.

Res.

2014,

472

(11),

3254–3262.

https://doi.org/10.1007/s11999-014-3543-8.
(2)

Abad, C. L.; Haleem, A. Prosthetic Joint Infections: An Update. Curr. Infect. Dis.
Rep. 2018, 20 (7), 15. https://doi.org/10.1007/s11908-018-0622-0.

47

(3)

Del Pozo, J. L.; Patel, R. Infection Associated with Prosthetic Joints. N. Engl. J.
Med. 2009, 361 (8), 787–794. https://doi.org/10.1056/NEJMcp0905029.

(4)

Esposito, S.; Leone, S. Prosthetic Joint Infections: Microbiology, Diagnosis,
Management and Prevention. Int. J. Antimicrob. Agents 2008, 32 (4), 287–293.
https://doi.org/10.1016/j.ijantimicag.2008.03.010.

(5)

Berbari, E. F.; Hanssen, A. D.; Duffy, M. C.; Steckelberg, J. M.; Ilstrup, D. M.;
Harmsen, W. S.; Osmon, D. R. Risk Factors for Prosthetic Joint Infection: Case‐
Control

Study.

Clin.

Infect.

Dis.

1998,

27

(5),

1247–1254.

https://doi.org/10.1086/514991.
(6)

Ricciardi, B. F.; Muthukrishnan, G.; Masters, E. A.; Kaplan, N.; Daiss, J. L.;
Schwarz, E. M. New Developments and Future Challenges in Prevention, Diagnosis,
and Treatment of Prosthetic Joint Infection. J. Orthop. Res. 2020, 38 (7), 1423–1435.
https://doi.org/10.1002/jor.24595.

(7)

Betsch, B. Y.; Eggli, S.; Siebenrock, K. A.; Täuber, M. G.; Mühlemann, K.
Treatment

of

Joint

Prosthesis

Infection

in

Accordance

with

Current

Recommendations Improves Outcome. Clin. Infect. Dis. 2008, 46 (8), 1221–1226.
https://doi.org/10.1086/529436.
(8)

Kurtz, S. M.; Lau, E. C.; Son, M.-S.; Chang, E. T.; Zimmerli, W.; Parvizi, J. Are We
Winning or Losing the Battle With Periprosthetic Joint Infection: Trends in
Periprosthetic Joint Infection and Mortality Risk for the Medicare Population. J.
Arthroplasty 2018, 33 (10), 3238–3245. https://doi.org/10.1016/j.arth.2018.05.042.

48

(9)

Garfield, K.; Noble, S.; Lenguerrand, E.; Whitehouse, M. R.; Sayers, A.; Reed, M.
R.; Blom, A. W. What Are the Inpatient and Day Case Costs Following Primary
Total Hip Replacement of Patients Treated for Prosthetic Joint Infection: A Matched
Cohort Study Using Linked Data from the National Joint Registry and Hospital
Episode Statistics. BMC Med. 2020, 18 (1), 335. https://doi.org/10.1186/s12916020-01803-7.

(10) Svensson, K. Diagnosis and Management of Periprosthetic Joint Infections. 2020.
(11) Akoh, J. A. Peritoneal Dialysis Associated Infections: An Update on Diagnosis and
Management.

World

J.

Nephrol.

2012,

1

(4),

106.

https://doi.org/10.5527/wjn.v1.i4.106.
(12) Porrino, J.; Wang, A.; Moats, A.; Mulcahy, H.; Kani, K. Prosthetic Joint Infections:
Diagnosis, Management, and Complications of the Two-Stage Replacement
Arthroplasty.

Skeletal

Radiol.

2020,

49

(6),

847–859.

https://doi.org/10.1007/s00256-020-03389-w.
(13) Parvizi, J.; Zmistowski, B.; Berbari, E. F.; Bauer, T. W.; Springer, B. D.; Della Valle,
C. J.; Garvin, K. L.; Mont, M. A.; Wongworawat, M. D.; Zalavras, C. G. New
Definition for Periprosthetic Joint Infection: From the Workgroup of the
Musculoskeletal Infection Society. Clin. Orthop. 2011, 469 (11), 2992–2994.
https://doi.org/10.1007/s11999-011-2102-9.
(14) Alijanipour, P.; Bakhshi, H.; Parvizi, J. Diagnosis of Periprosthetic Joint Infection:
The Threshold for Serological Markers. Clin. Orthop. Relat. Res. 2013, 471 (10),
3186–3195. https://doi.org/10.1007/s11999-013-3070-z.

49

(15) Garcia-Tsao, G.; Conn, H. O.; Lerner, E. The Diagnosis of Bacterial Peritonitis:
Comparison of PH, Lactate Concentration and Leukocyte Count. Hepatology 1985,
5 (1), 91–96. https://doi.org/10.1002/hep.1840050119.
(16) Keemu, H.; Vaura, F.; Maksimow, A.; Maksimow, M.; Jokela, A.; Hollmén, M.;
Mäkelä, K. Novel Biomarkers for Diagnosing Periprosthetic Joint Infection from
Synovial

Fluid

and

Serum.

JBJS

Open

Access

6

2021,

(2).

https://doi.org/10.2106/JBJS.OA.20.00067.
(17) Saleh, A.; George, J.; Faour, M.; Klika, A. K.; Higuera, C. A. Serum Biomarkers in
Periprosthetic

Joint

Infections.

Bone

Jt.

Res.

2018,

7

(1),

85–93.

https://doi.org/10.1302/2046-3758.71.BJR-2017-0323.
(18) Shahi, A.; Parvizi, J. The Role of Biomarkers in the Diagnosis of Periprosthetic Joint
Infection. EFORT Open Rev. 2016, 1 (7), 275–278. https://doi.org/10.1302/20585241.1.160019.
(19) Cyteval, C.; Bourdon, A. Imaging Orthopedic Implant Infections. Diagn. Interv.
Imaging 2012, 93 (6), 547–557. https://doi.org/10.1016/j.diii.2012.03.004.
(20) Potapova, I. Functional Imaging in Diagnostic of Orthopedic Implant-Associated
Infections.

Diagnostics

2013,

3

(4),

356–371.

https://doi.org/10.3390/diagnostics3040356.
(21) Odekerken, J. C. E.; Brans, B. T.; Welting, T. J. M.; Walenkamp, G. H. I. M.

18

F-

FDG MicroPET Imaging Differentiates between Septic and Aseptic Wound Healing
after Orthopedic Implant Placement: A Longitudinal Study of an Implant

50

Osteomyelitis in the Rabbit Tibia. Acta Orthop. 2014, 85 (3), 305–313.
https://doi.org/10.3109/17453674.2014.900894.
(22) Jacovides, C. L.; Parvizi, J.; Adeli, B.; Jung, K. A. Molecular Markers for Diagnosis
of Periprosthetic Joint Infection. J. Arthroplasty 2011, 26 (6), 99-103.e1.
https://doi.org/10.1016/j.arth.2011.03.025.
(23) Brannan, S. R.; Jerrard, D. A. Synovial Fluid Analysis. J. Emerg. Med. 2006, 30 (3),
331–339. https://doi.org/10.1016/j.jemermed.2005.05.029.
(24) Guenther, L. E.; Pyle, B. W.; Turgeon, T. R.; Bohm, E. R.; Wyss, U. P.; Schmidt, T.
A.; Brandt, J.-M. Biochemical Analyses of Human Osteoarthritic and Periprosthetic
Synovial Fluid. Proc. Inst. Mech. Eng. [H] 2014, 228 (2), 127–139.
https://doi.org/10.1177/0954411913517880.
(25) Fink, B.; Makowiak, C.; Fuerst, M.; Berger, I.; Schäfer, P.; Frommelt, L. The Value
of Synovial Biopsy, Joint Aspiration and C-Reactive Protein in the Diagnosis of Late
Peri-Prosthetic Infection of Total Knee Replacements. J. Bone Joint Surg. Br. 2008,
90-B (7), 874–878. https://doi.org/10.1302/0301-620X.90B7.20417.
(26) Lee, Y. S.; Koo, K.-H.; Kim, H. J.; Tian, S.; Kim, T.-Y.; Maltenfort, M. G.; Chen,
A. F. Synovial Fluid Biomarkers for the Diagnosis of Periprosthetic Joint Infection:
A Systematic Review and Meta-Analysis. J. Bone Jt. Surg. 2017, 99 (24), 2077–
2084. https://doi.org/10.2106/JBJS.17.00123.
(27) Deirmengian, C.; Hallab, N.; Tarabishy, A.; Della Valle, C.; Jacobs, J. J.; Lonner,
J.; Booth, R. E. Synovial Fluid Biomarkers for Periprosthetic Infection. Clin.

51

Orthop. Relat. Res. 2010, 468 (8), 2017–2023. https://doi.org/10.1007/s11999-0101298-4.
(28) Figueiredo, A.; Ferreira, R.; Alegre, C.; Judas, F.; Fonseca, F. Diagnosis of
Periprosthetic Joint Infection from from Novel Synovial Fluid Biomarkers to
Identification of the Etiological Agent. Bone Res. 2018, 2 (4), 555594.
(29) Parvizi, J.; McKenzie, J. C.; Cashman, J. P. Diagnosis of Periprosthetic Joint
Infection Using Synovial C-Reactive Protein. J. Arthroplasty 2012, 27 (8), 12–16.
https://doi.org/10.1016/j.arth.2012.03.018.
(30) Parvizi, J.; Jacovides, C.; Adeli, B.; Jung, K. A.; Hozack, W. J. Mark B. Coventry
Award: Synovial C-Reactive Protein: A Prospective Evaluation of a Molecular
Marker for Periprosthetic Knee Joint Infection. Clin. Orthop. Relat. Res. 2012, 470
(1), 54–60. https://doi.org/10.1007/s11999-011-1991-y.
(31) De Vecchi, E.; Romanò, C. L.; De Grandi, R.; Cappelletti, L.; Villa, F.; Drago, L.
Alpha Defensin, Leukocyte Esterase, C-Reactive Protein, and Leukocyte Count in
Synovial Fluid for Pre-Operative Diagnosis of Periprosthetic Infection. Int. J.
Immunopathol.

Pharmacol.

2018,

32,

1–6.

https://doi.org/10.1177/2058738418806072.
(32) Wyatt, M. C.; Beswick, A. D.; Kunutsor, S. K.; Wilson, M. J.; Whitehouse, M. R.;
Blom, A. W. The Alpha-Defensin Immunoassay and Leukocyte Esterase
Colorimetric Strip Test for the Diagnosis of Periprosthetic Infection: A Systematic
Review and Meta-Analysis. J. Bone Jt. Surg. 2016, 98 (12), 992–1000.
https://doi.org/10.2106/JBJS.15.01142.

52

(33) Chen, Y.; Kang, X.; Tao, J.; Zhang, Y.; Ying, C.; Lin, W. Reliability of Synovial
Fluid Alpha-Defensin and Leukocyte Esterase in Diagnosing Periprosthetic Joint
Infection (PJI): A Systematic Review and Meta-Analysis. J. Orthop. Surg. 2019, 14
(1), 453. https://doi.org/10.1186/s13018-019-1395-3.
(34) Gollwitzer, H.; Dombrowski, Y.; Prodinger, P. M.; Peric, M.; Summer, B.;
Hapfelmeier, A.; Saldamli, B.; Pankow, F.; von Eisenhart-Rothe, R.; Imhoff, A. B.;
Schauber, J.; Thomas, P.; Burgkart, R.; Banke, I. J. Antimicrobial Peptides and
Proinflammatory Cytokines in Periprosthetic Joint Infection. J. Bone Jt. Surg. 2013,
95 (7), 644–651. https://doi.org/10.2106/JBJS.L.00205.
(35) Lenski, M.; Scherer, M. A. Synovial IL-6 AS Inflammatory Marker in Periprosthetic
Joint

Infections.

J.

Arthroplasty

2014,

29

(6),

1105–1109.

https://doi.org/10.1016/j.arth.2014.01.014.
(36) Berger, P.; Van Cauter, M.; Driesen, R.; Neyt, J.; Cornu, O.; Bellemans, J. Diagnosis
of Prosthetic Joint Infection with Alpha-Defensin Using a Lateral Flow Device: A
Multicentre

Study.

Bone

Jt.

J.

2017,

99-B

(9),

1176–1182.

https://doi.org/10.1302/0301-620X.99B9.BJJ-2016-1345.R2.
(37) Bingham, J.; Clarke, H.; Spangehl, M.; Schwartz, A.; Beauchamp, C.; Goldberg, B.
The Alpha Defensin-1 Biomarker Assay Can Be Used to Evaluate the Potentially
Infected Total Joint Arthroplasty. Clin. Orthop. Relat. Res. 2014, 472 (12), 4006–
4009. https://doi.org/10.1007/s11999-014-3900-7.
(38) Bonanzinga, T.; Zahar, A.; Dütsch, M.; Lausmann, C.; Kendoff, D.; Gehrke, T. How
Reliable Is the Alpha-Defensin Immunoassay Test for Diagnosing Periprosthetic

53

Joint Infection? A Prospective Study. Clin. Orthop. 2017, 475 (2), 408–415.
https://doi.org/10.1007/s11999-016-4906-0.
(39) Stone, W. Z.; Gray, C. F.; Parvataneni, H. K.; Al-Rashid, M.; Vlasak, R. G.;
Horodyski, M.; Prieto, H. A. Clinical Evaluation of Synovial Alpha Defensin and
Synovial C-Reactive Protein in the Diagnosis of Periprosthetic Joint Infection. J.
Bone Jt. Surg. 2018, 100 (14), 1184–1190. https://doi.org/10.2106/JBJS.17.00556.
(40) Deirmengian, C.; Kardos, K.; Kilmartin, P.; Cameron, A.; Schiller, K.; Booth, R. E.;
Parvizi, J. The Alpha-Defensin Test for Periprosthetic Joint Infection Outperforms
the Leukocyte Esterase Test Strip. Clin. Orthop. 2015, 473 (1), 198–203.
https://doi.org/10.1007/s11999-014-3722-7.
(41) Ahmad, S. S.; Hirschmann, M. T.; Becker, R.; Shaker, A.; Ateschrang, A.; Keel, M.
J. B.; Albers, C. E.; Buetikofer, L.; Maqungo, S.; Stöckle, U.; Kohl, S. A MetaAnalysis of Synovial Biomarkers in Periprosthetic Joint Infection: SynovasureTM Is
Less Effective than the ELISA-Based Alpha-Defensin Test. Knee Surg. Sports
Traumatol. Arthrosc. 2018, 26 (10), 3039–3047. https://doi.org/10.1007/s00167018-4904-8.
(42) Deirmengian, C.; Kardos, K.; Kilmartin, P.; Gulati, S.; Citrano, P.; Booth, R. E. The
Alpha-Defensin Test for Periprosthetic Joint Infection Responds to a Wide Spectrum
of

Organisms.

Clin.

Orthop.

2015,

473

(7),

2229–2235.

https://doi.org/10.1007/s11999-015-4152-x.
(43) Deirmengian, C.; Feeley, S.; Kazarian, G. S.; Kardos, K. Synovial Fluid Aspirates
Diluted with Saline or Blood Reduce the Sensitivity of Traditional and

54

Contemporary Synovial Fluid Biomarkers. Clin. Orthop. 2020, 478 (8), 1805–1813.
https://doi.org/10.1097/CORR.0000000000001188.
(44) Kerolus, G.; Clayburne, G.; Schumacher, H. R. Is It Mandatory to Examine Synovial
Fluids Promptly after Arthrocentesis? Arthritis Rheum. 1989, 32 (3), 271–278.
https://doi.org/10.1002/anr.1780320308.
(45) Barnett, C. H. Measurement and Interpretation of Synovial Fluid Viscosities. Ann.
Rheum. Dis. 1958, 17 (2), 229–233. https://doi.org/10.1136/ard.17.2.229.
(46) Fu, J.; Ni, M.; Chai, W.; Li, X.; Hao, L.; Chen, J. Synovial Fluid Viscosity Test Is
Promising for the Diagnosis of Periprosthetic Joint Infection. J. Arthroplasty 2019,
34 (6), 1197–1200. https://doi.org/10.1016/j.arth.2019.02.009.
(47) Ogston, A. G.; Stanier, J. E. The Physiological Function of Hyaluronic Acid in
Synovial Fluid; Viscous, Elastic and Lubricant Properties. J. Physiol. 1953, 119 (2–
3), 244–252. https://doi.org/10.1113/jphysiol.1953.sp004842.
(48) Tamer, T. M. Hyaluronan and Synovial Joint: Function, Distribution and Healing.
Interdiscip. Toxicol. 2013, 6 (3), 111–125. https://doi.org/10.2478/intox-2013-0019.
(49) Ropes, M. W.; Bennett, G. A.; Bauer, W. The Origin and Nature of Normal Synovial
Fluid. J. Clin. Invest. 1939, 18 (3), 351–372. https://doi.org/10.1172/JCI101050.
(50) Swann, D. A.; Radin, E. L.; Nazimiec, M.; Weisser, P. A.; Curran, N.; Lewinnek,
G. Role of Hyaluronic Acid in Joint Lubrication. Ann. Rheum. Dis. 1974, 33 (4),
318–326. https://doi.org/10.1136/ard.33.4.318.
(51) Mazzucco, D. Variation in Joint Fluid Composition and Its Effect on the Tribology
of Replacement Joint Articulation. 286.

55

(52) Myant, C.; Underwood, R.; Fan, J.; Cann, P. M. Lubrication of Metal-on-Metal Hip
Joints: The Effect of Protein Content and Load on Film Formation and Wear. J.
Mech.

Behav.

Biomed.

Mater.

2012,

6,

30–40.

https://doi.org/10.1016/j.jmbbm.2011.09.008.
(53) Galandáková, A.; Ulrichová, J.; Langová, K.; Hanáková, A.; Vrbka, M.; Hartl, M.;
Gallo, J. Characteristics of Synovial Fluid Required for Optimization of Lubrication
Fluid for Biotribological Experiments. J. Biomed. Mater. Res. B Appl. Biomater.
2017, 105 (6), 1422–1431. https://doi.org/10.1002/jbm.b.33663.
(54) Sundblad, L. The Chemistry of Synovial Fluid with Special Regard to Hyaluronic
Acid.

Acta

Orthop.

Scand.

1950,

20

(2),

105–113.

https://doi.org/10.3109/17453675009043408.
(55) Sheely, M. L. Glycerol Viscosity Tables. Ind. Eng. Chem. 1932, 24 (9), 1060–1064.
https://doi.org/10.1021/ie50273a022.
(56) Segur, J. B.; Oberstar, H. E. Viscosity of Glycerol and Its Aqueous Solutions. Ind.
Eng. Chem. 1951, 43 (9), 2117–2120.
(57) Gonzalez-Tello, P.; Camacho, F.; Blazquez, G. Density and Viscosity of
Concentrated Aqueous Solutions of Polyethylene Glycol. J. Chem. Eng. Data 1994,
39 (3), 611–614. https://doi.org/10.1021/je00015a050.
(58) Jebens, E. H.; Monk-Jones, M. E. On the Viscosity and PH of Synovial Fluid and
the PH of Blood. J. Bone Joint Surg. Br. 1959, 41 (2), 388–400.
(59) Francis, A. W. Wall Effect in Falling Ball Method for Viscosity. Physics 1933, 4
(11), 403–406. https://doi.org/10.1063/1.1745151.

56

(60) Brizard, M.; Megharfi, M.; Mahé, E.; Verdier, C. Design of a High Precision FallingBall

Viscometer.

Rev.

Sci.

Instrum.

https://doi.org/10.1063/1.1851471.

57

2005,

76

(2),

025109.

CHAPTER FIVE
CONCLUSIONS AND FUTURE WORK
5.1. Conclusions
A new generation of implantable chemical sensors that gives physicians the ability
to measure local chemical concentrations from routine radiographs is developed. The
approach is especially promising for detecting and monitoring implant-associated
infections. The applications of the sensor presented in this dissertation are focused on
prosthetic joint infections and aim to develop the first implantable sensors that can be read
directly through X-ray imaging for early, non-invasive determination of prosthetic joint
infections. The goal is to functionalize X-ray imaging which is a widely available,
indispensable tool for detecting and monitoring disease conditions, however, cannot
provide any biochemical information.1,2 The sensors developed here are based on a pHresponsive hydrogel with radiopaque markers in order to enable length measurements using
X-ray imaging. The sensors are small enough for integration into a prosthesis and enable
local biochemical measurements at the site of the infection itself by X-ray radiography.
The sensors use a robust, passive mechanism based on hydrogel swelling chemical
equilibrium with minimum effects from the matrix and less susceptible to drift from aging
and biofouling and do not require frequent recalibration, or implantation of new sensor
devices with time.
Both the synovial fluid pH and carbon dioxide sensors are based on the length
changes of polyacrylic acid-based hydrogel in response to pH. The performance of the
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hydrogel in vitro in buffer, bovine serum, bovine synovial fluid, human peritoneal fluid
shows good linearity and reversibility with minimal effects from the matrix. Previous
studies on the performance of the pH-responsive hydrogel in culture media and incubation
in highly oxidative environments for a month containing hydrogen peroxide and copper
ions also showed similar results, with minimal matrix effects.3 X-ray images of the synovial
pH and carbon dioxide sensor on a hip prosthesis show that the markers are clearly seen in
the radiographs. Studies of the sensor in an in vivo model in a rat peritoneal infection study
showed the sensor location in the rat clearly and a pH drop was observed during infection
not observed in the control. In addition, postmortem measurements showed that the sensors
had not drifted or changed calibration after implantation for two weeks. While these results
are in a peritoneal cavity rather than a prosthetic hip, they are consistent with in vitro results
showing minimal effect from varying the matrices. The carbon dioxide sensor has the
additional advantage of the hydrogel being separated from the external environment by a
gas-permeable membrane which will significantly reduce the potential for biofouling.
Preliminary studies show the potential to use both sensors together in a prosthesis as a dual
sensor which will enable simultaneous measurement of both synovial fluid pH and carbon
dioxide levels which will be important in the diagnosis of infections and improve reliability
of the sensor.
The falling bead synovial fluid viscosity sensor provides a simple way to determine
prosthetic joint infections early by X-ray radiography by measuring the change in rate/ time
taken for the bead to fall will be an indication of infections due to a decrease in viscosity
during infections. The use of a reference fluid in a separate tube was also an important way
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to improve viscosity resolution, especially near clinically determined viscosity thresholds.
The sensor has the potential to be developed to provide noninvasive measurements of
synovial fluid viscosity measurements in the detection of prosthetic joint infections, early.
The main advantage of the developed sensors is that they can be easily implemented
in already available clinical settings, avoid the use of electronics or other complex
instrumentation, and do not require special personnel for analyzing the data. The sensors
can be attached easily to the prosthesis prior to implantation without any additional
modifications to the already available commercial prosthesis. For hip infections, the pH
and carbon dioxide sensor can be attached to the neck of the prosthesis so that the sensor
will be in contact with synovial fluid. For the other joints, the sensor casing can be slightly
modified to fit into the prosthesis joint. In the case of the viscosity sensor, sensor design
can be modified to fit the joint of interest which would enable X-ray imaging of the sensor.
Other advantages of the radiographic sensor approaches discussed in the dissertation
include simplicity, speed (radiographs already routinely acquired), more reliable
immersion in synovial fluid with no risk of dilution or drift between fluid removal and
analysis, and easier repeated analysis compared to other methods of synovial fluid analysis.
In summary, the designed sensors are simple, easy to develop, manufacture, and
integrate into clinical settings. Such an X-ray visualized synovial sensor has not been
developed before and it has the potential to be expanded for other types of biomarkers as
well by using a different stimuli-responsive hydrogel. The sensors functionalize plain
radiography which will greatly facilitate clinical adoption with potentially transformative
orthopedic applications for detecting, monitoring, and studying implant infections.
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5.2. Future Work
Future work with regard to clinical applications, both the pH sensor and carbon
dioxide sensor performance needs to be tested ex vivo and in vivo. The effect of tissue and
bone on X-ray contrast in a patient can be determined by ex vivo imaging of sensor using
human cadavers and similar results to the in vitro model are expected. Using the Hawkin’s
Surgical Innovation center, the sensor will be tested ex vivo in two human cadaver
specimens to show that the measurements can be performed using a standard X-ray unit.
The sensor will be attached to a prosthetic hip and implanted in a human cadaver. Via
synovial capsule injections, the pH will be cycled from 6.9 to 7.4 and back, while X-ray
images are acquired every 5 minutes. The two cadaver specimens will be radiographed
sequentially. To measure interobserver variation, multiple physicians will report the
position of a random selection of the images. Measurements can be made based on both
the scale position and, more precisely, using a DICOM viewer. In a related cadaver study
with a prototype pH sensor on a tibial plate;4 the sensor accurately responded over a pH 48 range with less sensitivity around pH 7; nonetheless, it had a 30 min reversible response
time and inter-observer variation corresponding to 0.1 units. Similar to the pH sensor, the
interobserver reliability of the carbon dioxide sensor will be measured by determining the
position of the tantalum bead from the X-ray images by multiple observers.
The sensor performance in vivo can be determined by implanting the sensors in a
sheep infection model. The sensors can be designed so that both sensors will fit the neck
of the prosthesis so that they will be in contact with the synovial fluid and simultaneous
measurements of pH and carbon dioxide levels can be determined and compared. A
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prepilot study will be used to validate the ability of the sensors to detect and report synovial
fluid pH and carbon dioxide levels surrounding the neck of a hip prosthesis and confirm
that the readings correspond to infection in vivo. Arthrocentesis will be carried out
periodically during the study, to test the aspirated synovial fluid for pH (pH electrode),
carbon dioxide (gas analyzer), for biomarkers of infection such as C-reactive protein (blood
analyzer machine).
The animal use protocol for the pH sensor is already approved for testing the sensor
performance in a sheep model. Various animal species have been used as models of human
orthopedic pathologic conditions, including non-human primates, dogs, cats, pigs, cattle,
horses, sheep, goats, rabbits, guinea pigs, rats, and mice.5 Even though rats and mice are
commonly used, due to their small size, they can only be used for studies involving basic
orthopedics and require special instrumentation and surgical techniques. 5 Out of the other
available animal models, sheep are commonly used in vivo experimental models in
orthopedic research applications.5–8 Domestic sheep are placid animals and allows dor easy
handling during experiments. Their body weight similar to humans and sufficiently large
to allow serial sampling and multiple experimental procedures. These features allow
researchers to conduct a proper evaluation of orthopedic implants produced with
dimensions for use in humans.5,7
For the pre-pilot study to ensure proper surgical placement and imaging and sensor
performance in vitro, two sheep will be used, one as the control and the other infected. The
sheep will be acquired from an appropriate vendor and housed at Godley-Snell Research
Center (GSRC). Hip radiographs will be taken of each sheep before purchase to ensure the
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sheep are able to accommodate the hip implant. Each sheep will undergo a complete
physical examination including a radiographic assessment to ensure the femur can
accommodate the prosthetic hip implant. The sheep will be acclimated for 10 days during
which they will be trained on the measurement technique (standing radiographs taken on
scale or pressure mat). Sheep will be weighed on the day of surgery to establish baseline
and once per week thereafter and will be monitored for normal activity, food and water
consumption and fecal and urine output. The sheep will be randomly treated unilaterally
with a total hip replacement using a hip implant (Biomedtrix, USA) with the pH sensor
and/or carbon dioxide sensor attached to it.6 For one of the sheep, the implant with sensor
will be inoculated in a region with Staphylococcus aureus (5000 cfu) before closing the
incision. Post-surgery, standing X-ray images will be taken weekly for 10 weeks.
Radiographs acquired to ensure proper implant positioning and integration using either the
table-top or portable X-ray system. If necessary, the animal will be imaged under light
anesthesia. Each week, arthrocentesis will be performed using aseptic technique, under
anesthesia previously described, to collect synovial fluid samples (1 mL) and compare the
sensor response to synovial fluid pH, CO2 level, viscosity. After 10 weeks, sheep will be
euthanized with commercial euthanasia solution and a terminal 10 ml blood sample
obtained. We will analyze the blood for toxicity and/or inflammatory markers such as
cytokines, C-reactive protein (CRP), and/or leukocyte count to inform us in the event of an
infection or an inflammatory response. Synovial fluid will be drawn to analyze for infection
biomarkers and pH. The sensors will be extracted and checked for sensor performance
(accuracy, precision, reversibility, and response rate in alternating pH 7.5/6.5 buffers).
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The 21-day pilot study will be performed with six sheep with 3 infected and 3
aseptic surgeries. In each sheep, a Biomedtrix prosthetic hip implant with the pH sensor
and/or carbon dioxide sensor attached will be surgically implanted. Postoperatively,
radiographic pH readings will be acquired, along with measurement of core temperature,
serum CRP and ESR levels, synovial fluid WBC, and alpha defensin. In postmortem
specimens, the histology and local chemical environment, and sensor performance will be
analyzed. Based on prior literature, an initial pH drop of ~ 0.5 pH units in synovial fluid
within 24 hours and continuing throughout the 3 weeks is expected. A 21-day trial was
selected because most implant infections occur early, and the cut-off point for early
infection is generally less than two weeks. The 3-week pilot study will allow us to observe
restoration of pH after the initial acute inflammatory phase in week one but is not long
enough for the infection to clear.
Periodic collection of blood samples from the sheep can be analyzed for serum nonspecific markers of inflammation such as CRP levels and erythrocyte sedimentation rate
(ESR), and arthrocentesis can be performed to aspirate synovial fluid samples which can
be analyzed for synovial fluid pH, lactate and alpha-defensin to compare the levels in
control and infected sheep. Postmortem, the pH near the implant will be compared with the
radiographic measurements, and three sensors in each group will be incubated in pH 7.4
and 6.9 buffers to verify the calibration curve and measure the response rate. Histology
will be performed to observe evidence for tissue growth, chronic inflammatory response,
and/or infection.
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For the falling bead synovial fluid viscosity sensor, the movement of the bead needs
to be slowed down enough (a velocity of 1 mm/s in a 10 mPas viscous solution) for the
determination of the position of the bead from X-ray images. The sensor design needs to
be modified by using a porous tube in order for the diffusion of external synovial fluid. In
vitro tests regarding the specificity of the sensor for viscosity and effect of surrounding
external environment need to be assessed. In vitro studies need to be performed for the
sensor using X-ray imaging. Following in vitro tests, the sensor will be attached to a
prosthesis and X-ray images will be taken ex vivo in a cadaver model and in vivo in a sheep
model.

5.2.1. CRP sensor
The pH sensor can be modified by replacing the pH-responsive hydrogel with an
antigen responsive hydrogel that responds to the presence of a particular biomarker in
synovial fluid. As a preliminary study, a C-Reactive protein (CRP) hydrogel was
developed. C-reactive protein (CRP) is an acute-phase plasma protein and increases at sites
of infection or inflammation.9–11 CRP is produced as a homopentameric protein, which can
irreversibly dissociate into five separate monomers at sites of infection or inflammation. 9,10
It is synthesized mainly in liver hepatocytes, and also by smooth muscle cells,
macrophages, endothelial cells, lymphocytes, and adipocytes.10,12 It is normally found at
concentrations less than 10 mg/L in the blood.10,11 During infectious or inflammatory
disease states, CRP levels rise rapidly and peak at levels of up to 350–400 mg/L after 48
hours. Even though serum CRP levels are routinely analyzed for prosthetic joint infection
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diagnosis,13–15 they lack specificity for joint infections. Studies have shown local CRP
levels in synovial fluid are a better biomarker of prosthetic joint infections, however,
analysis is only possible by aspirating synovial fluid by arthrocentesis. 16–18 Therefore, a
sensor to measure local CRP levels at the site of the infection itself using routinely available
X-ray imaging will be useful in the diagnosis of prosthetic joint infections.
A biomolecule-responsive hydrogel with reversible swelling previously reported
method by Miyata et al. will be used to design the CRP hydrogel.19–21 Miyata et al.
developed a bioconjugated semi-interpenetrating network (semi-IPN) hydrogel that could
be actuated by antigen-antibody complexion between the rabbit immunoglobulin G (IgG)
antigen and goat anti-rabbit IgG (GAR IgG) antibody. In this approach, an antigenantibody semi-interpenetrating network hydrogel was synthesized consisting of polymer
networks with antigens and linear polymers with antibodies. In design of the CRP
responsive hydrogel, the rabbit immunoglobulin G (IgG) antigen was replaced with CRP,
and goat anti-rabbit IgG (GAR IgG) antibody was replaced with CRP antibody.
In the preparation of the CRP sesnitive hydrogel, the antibody (Anti-CRP) was
chemically modified by coupling it with N-succinimidyl acrylate (NSA) in phosphate
buffer solution. NSA (0.4 mg) was added to a phosphate buffer solution (0.02 M, pH 7.4)
containing Anti-CRP (100 mg), and the reaction mixture was incubated at 36 ˚C for one
hour to introduce the vinyl groups into the Anti-CRP. The resultant vinyl(Anti-CRP) (570
mg) was added to acrylamide (AAm) (30 mg), with 0.01 mL of 0.1 M aqueous ammonium
persulphate (APS) and 0.01 mL of 0.8 M aqueous N,N,N',N'-tetramethylethylenediamine
(TEMED) as redox initiators. The copolymerization was performed at 25 ˚C for 3 h to
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synthesize the polymerized Anti-CRP. Similarly, vinyl(CRP) was synthesized by
modifying CRP (100 mg) with NSA (0.4 mg) in PBS (0.02 M, pH 7.4) and incubated at 36
˚C for 1 hour. The resultant vinyl(CRP) (2.46 mg), AAm (82 mg) and N,N'methylenebisacrylamide (MBAA) (0.1 weight% relative to AAm) as a crosslinker were
dissolved in 600 mg of PBS containing the polymerized Anti-CRP. As soon as aqueous
APS (0.01 mL, 0.1 M) and aqueous TEMED (0.01 mL, 0.8 M) were added into the mixture
as redox initiators, the solution was injected into a reaction cell and polymerized at 25 ˚C
for 3 h. After the polymerization, the resultant hydrogels were immersed in phosphate
buffer to remove any residual chemicals and unreacted monomers. Polyacrylamide
(PAAm) hydrogel was also prepared as a control by the redox copolymerization of AAm
and MBAA in the presence of redox initiators.
Preliminary results of the CRP hydrogel showed swelling and deswelling in the
presence and absence of antigen (Figure 5.1). The sensor will need to be optimized for
clinically relevant response range and test its long-term stability in synovial fluid. The
synovial fluid CRP sensor design would be similar to X-ray based discussed in the
dissertation, with the responsive hydrogel with embedded radiopaque bead enclosed in a
casing and attached to a hip prosthesis. After characterization of the sensor in vitro, X-ray
imaging of sensor in cadaveric model will be carried out. In vivo studies to determine
sensor performance will be performed in a sheep model.
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Figure 5.1: Preliminary results of response of CRP responsive hydrogel to external
solutions of CRP.

5.2.2. Glucose sensor
A preliminary study was conducted to extend the hydrogel pH sensor to detect
synovial fluid glucose by incorporating enzymes glucose oxidase and catalase. Normally,
synovial fluid glucose levels are less than 10 mg/dL lower than serum levels.23,24 Joint
disorders that are classified as infectious demonstrate large decreases in synovial fluid
glucose and can be as much as 20–100 mg/dL less than serum levels. The hydrogel will be
modified by incorporating glucose oxidase and catalase enzymes. It is expected that due to
oxidation of glucose to gluconic acid by glucose oxidase enzyme, there would be a decrease
in the pH of the solution. Catalase enzyme is added to remove the produced hydrogen
peroxide.
In the preparation of the glucose responsive hydrogel, since glucose oxidase and
catalase enzymes did not dissolve in dimethylformamide (DMF), 70% ethanol was used to
prepare the hydrogel. Glucose oxidase (3 mg) and catalase (3 mg) were dissolved first in
100 µL of water:DMF (70:30) solution. In a separate vial, the reagents for the preparation
the polyacrylic acid hydrogel were mixed (10% acrylic acid, 5% n-octyl acrylate, 1%
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polyethyleneglycol diacrylate, 0.1 % 2-oxoglutaric acid in DMF). The enzyme mix was
then added dropwise to the hydrogel mix and a pale-yellow solution was obtained. The
mixture was polymerized in a reaction cell, in a nitrogen atmosphere in a glove box under
UV irradiation. The resultant hydrogels were washed with 70% ethanol.
In order to measure the response of the hydrogel to different glucose solutions,
hydrogel disks were placed in different glucose concentrations and placed in an incubator
at 37 ˚C. The preliminary results show that there is a change in the size of the hydrogel
(0.562 mm) upon leaving the gels in a solution of glucose (Figure 5.2). This shows that the
pH sensitive hydrogel could be improved by incorporating different molecular recognition
elements to be specific to a particular biomarker for the detection, treatment, and progress
of diseases. Incorporation of different molecular recognition elements to the pH sensitive
hydrogel to sense multiple biomarkers that are useful in diagnosis of diseases.

Figure 5.2: Polyacrylic acid hydrogel containing glucose oxidase and catalase, initial (left)
and after leaving in glucose solution (right).
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In summary, we developed and validated implantable sensors to radiographically
measure various biomarkers of infection for early detection of prosthetic joint infections.
The designed sensors are simple, easy to read and not limited to a particular disease
condition and can be modifies to detect a broad range of diseases. The sensor is easily
modified to any specific biomarker of interest for a particular disease condition. The
approach promises to functionalize plain film radiography, providing local chemical
analysis using ubiquitous infrastructure and standard of care procedures.
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